Medicine – Renovascular Disease

Renovascular disease refers to narrowing or obstruction of the renal arteries or their major branches, resulting in reduced renal perfusion. The most important clinical consequence is renovascular hypertension, but severe disease can also cause recurrent pulmonary oedema, progressive chronic kidney disease, or acute kidney injury.

The two major causes are:

Atherosclerotic renal artery stenosis, usually in older patients with widespread vascular disease.

Fibromuscular dysplasia, more often seen in younger patients, especially women.

1. Association with Generalised Vascular Disease

Atherosclerotic renovascular disease is strongly associated with:

Coronary artery disease.

Peripheral arterial disease.

Cerebrovascular disease.

Aortic atherosclerosis.

This is because renal artery stenosis is often one manifestation of widespread systemic atherosclerosis.

2. Why Prognosis May Be Poor

Patients with atherosclerotic renovascular disease often have substantial cardiovascular comorbidity.

Therefore, prognosis may be adversely affected by:

Myocardial infarction.

Stroke.

Heart failure.

Peripheral vascular disease.

Progressive kidney disease.

The poor prognosis is often related not only to the renal artery lesion itself, but also to the patient’s overall cardiovascular disease burden.

3. Renovascular Hypertension

Reduced renal perfusion stimulates the:

Renin–angiotensin–aldosterone system.

The sequence is:

Renal artery narrowing → reduced renal perfusion → renin release → angiotensin II → vasoconstriction + aldosterone release → hypertension.

This produces:

Renovascular hypertension.

4. Clinical Clues to Renovascular Hypertension

Renovascular hypertension should be considered when hypertension is:

Severe.

Resistant to multiple antihypertensive drugs.

Sudden in onset.

Worsening after previously stable control.

Associated with unexplained renal impairment.

5. Age Pattern

The age of onset can provide a clue.

Older patient + widespread atherosclerosis → think atherosclerotic renal artery stenosis.

Younger patient, especially a woman + hypertension → think fibromuscular dysplasia.

6. Flash Pulmonary Oedema

One of the most important clinical presentations is:

Recurrent flash pulmonary oedema.

This is particularly associated with:

Bilateral severe renal artery stenosis

or

Severe stenosis affecting a solitary functioning kidney.

7. Why Flash Pulmonary Oedema Occurs

Reduced renal perfusion activates:

RAAS.

This causes:

Sodium retention.

Water retention.

Vasoconstriction.

Rapid elevation of blood pressure.

The result can be sudden fluid redistribution and:

Acute pulmonary oedema.

A useful association is:

Recurrent unexplained flash pulmonary oedema + severe hypertension → consider renovascular disease.

8. Chronic Kidney Disease

Renovascular disease can lead to progressive:

Chronic kidney disease, or CKD.

The older term:

CRF – chronic renal failure

is now generally replaced by:

CKD.

Long-standing reduction in renal perfusion may lead to:

Ischaemic nephropathy.

9. Ischaemic Nephropathy

Ischaemic nephropathy refers to chronic renal dysfunction caused by inadequate renal blood flow, usually due to significant renal artery stenosis.

Over time, the affected kidney may become:

Smaller.

Atrophic.

Poorly functioning.

10. End-Stage Kidney Disease

Severe bilateral renovascular disease can eventually contribute to:

End-stage kidney disease, or ESKD.

The older term:

ESRF

is now usually replaced by:

ESKD.

However, progression to kidney failure is not inevitable in every patient with renal artery stenosis.

11. Acute Kidney Injury after ACE Inhibitors or ARBs

An important clinical clue is deterioration in renal function after starting:

An ACE inhibitor

or

An angiotensin II receptor blocker, or ARB.

This is particularly concerning for:

Bilateral renal artery stenosis

or

Stenosis of the renal artery supplying a solitary functioning kidney.

12. Why ACE Inhibitors Can Cause AKI

In renal artery stenosis, renal perfusion pressure is reduced.

The kidney partly maintains GFR by using:

Angiotensin II-mediated constriction of the efferent arteriole.

This helps preserve pressure within the glomerulus.

13. Effect of ACE Inhibition

ACE inhibitors and ARBs reduce the effect of angiotensin II.

Therefore:

Efferent arteriole dilates → intraglomerular pressure falls → GFR decreases.

If both kidneys depend heavily on angiotensin II to maintain filtration, a marked rise in creatinine can occur.

14. High-Yield Pattern

Remember:

ACE inhibitor/ARB + sudden significant rise in creatinine → think bilateral renal artery stenosis.

This does not mean every small creatinine rise indicates renovascular disease.

A modest rise can occur normally after RAAS blockade, but a large or rapidly progressive increase should prompt reassessment.

15. Unilateral Renal Artery Stenosis

In unilateral disease, the unaffected kidney can often maintain overall renal function.

Therefore, ACE inhibitors may still be used in selected patients with:

Unilateral renal artery stenosis

provided renal function and potassium are monitored carefully.

16. Bilateral Renal Artery Stenosis

In significant bilateral disease, both kidneys may depend on angiotensin II to maintain glomerular filtration.

Therefore, ACE inhibitors and ARBs can cause:

Marked deterioration in renal function.

This makes bilateral disease clinically much more important.

17. Renal Bruit

A possible physical examination finding is:

Abdominal or flank bruit.

A renal artery bruit may support suspicion of renovascular disease, especially when hypertension is severe or resistant.

However, its absence does not exclude renal artery stenosis.

18. Atherosclerotic Renal Artery Stenosis

This is the most common form of renovascular disease in older adults.

Typical risk factors include:

Smoking.

Hypertension.

Diabetes.

Hyperlipidaemia.

Established atherosclerotic cardiovascular disease.

Lesions commonly involve the:

Ostium or proximal renal artery.

19. Fibromuscular Dysplasia

Fibromuscular dysplasia is a non-atherosclerotic, non-inflammatory arterial disease.

It typically affects:

Younger or middle-aged women.

It commonly involves the:

Mid-to-distal renal artery.

20. String-of-Beads Appearance

Fibromuscular dysplasia can produce the classic angiographic:

“String-of-beads” appearance.

This reflects alternating areas of:

Arterial stenosis

and

Aneurysmal dilatation.

21. Ultrasound

Renal ultrasonography may show:

Asymmetrical kidney size.

The kidney supplied by a chronically stenosed renal artery may become:

Smaller and atrophic.

This can be an important clue.

22. Duplex Doppler Ultrasound

A more useful modern vascular test is:

Renal artery duplex Doppler ultrasonography.

This can estimate blood-flow velocity and help detect haemodynamically significant stenosis.

Advantages include:

No ionising radiation.

No iodinated contrast.

Limitations include:

Operator dependence.

Difficulty in obesity or bowel gas.

23. Captopril Renogram

The original notes list:

Captopril renography.

This was historically used to identify functionally significant renal artery stenosis.

However, it is now used much less commonly because:

CT angiography

and

MR angiography

usually provide better anatomical assessment.

24. CT Angiography

CT angiography, or CTA, provides detailed imaging of the renal arteries.

It can demonstrate:

Location of stenosis.

Severity of narrowing.

Associated aortic atherosclerosis.

Its limitations include exposure to:

Ionising radiation

and

Iodinated contrast.

25. MR Angiography

MR angiography, or MRA, can also visualise the renal arteries.

It may be useful when CTA is unsuitable.

However, image quality, availability, renal function, and contrast considerations influence the choice of modality.

26. Conventional Angiography

Catheter-based renal angiography remains the anatomical reference standard.

However, because it is invasive, it is usually reserved for situations where:

Diagnosis remains uncertain

or

An endovascular intervention is being considered.

27. Investigation Strategy

A simplified modern approach is:

Clinical suspicion → renal ultrasound/duplex Doppler → CTA or MRA if appropriate → invasive angiography when intervention is planned or uncertainty remains.

The exact sequence depends on:

Renal function.

Contrast risk.

Local expertise.

Likelihood of intervention.

28. Treatment Principles

Treatment depends on:

Cause of the stenosis.

Severity of hypertension.

Renal function.

Presence of recurrent pulmonary oedema.

Anatomy of the lesion.

Whether the patient has fibromuscular dysplasia or atherosclerotic disease.

29. Medical Therapy

For many patients with atherosclerotic renal artery stenosis, the main treatment is:

Optimal medical therapy.

This includes:

Blood-pressure control.

Lipid lowering.

Antiplatelet therapy when indicated for atherosclerotic disease.

Smoking cessation.

Diabetes management.

30. Antihypertensive Therapy

Blood pressure should be treated appropriately.

Possible agents include:

ACE inhibitors or ARBs in selected patients.

Calcium-channel blockers.

Beta blockers.

Diuretics.

Choice depends on renal function, potassium, unilateral versus bilateral disease, and clinical tolerance.

31. ACE Inhibitors and ARBs

ACE inhibitors or ARBs can be very effective in renovascular hypertension, particularly with unilateral disease.

However:

Renal function and serum potassium must be monitored.

A marked creatinine rise should raise concern for:

Bilateral severe stenosis

or

Stenosis of a solitary functioning kidney.

32. Aspirin

The original treatment list includes:

Aspirin.

This is not used because it directly treats the renal artery stenosis.

It may be used because many patients have:

Atherosclerotic cardiovascular disease.

Thus antiplatelet therapy is used according to overall cardiovascular indications.

33. Lipid-Lowering Therapy

Statin therapy is important in atherosclerotic renovascular disease because these patients commonly have widespread vascular disease.

The aim is to reduce:

Cardiovascular events.

Stroke risk.

Progression of systemic atherosclerosis.

34. Angioplasty

Percutaneous transluminal renal angioplasty may be used to restore renal artery blood flow.

Its role differs greatly depending on the underlying cause.

35. Fibromuscular Dysplasia and Angioplasty

In fibromuscular dysplasia:

Angioplasty without routine stenting

is often an effective treatment.

It may significantly improve or occasionally cure:

Hypertension.

This is one of the clearest indications for renal artery angioplasty.

36. Atherosclerotic Renal Artery Stenosis and Stenting

In atherosclerotic renal artery stenosis, routine angioplasty and stenting are not beneficial for every patient compared with good medical therapy.

Therefore, revascularisation is generally reserved for selected high-risk situations.

37. When Revascularisation May Be Considered

Important situations include:

Recurrent flash pulmonary oedema.

Recurrent unexplained heart failure associated with severe renal artery stenosis.

Rapidly declining kidney function with haemodynamically significant bilateral disease.

Severe resistant hypertension despite appropriate medical treatment.

Significant stenosis of a solitary functioning kidney.

38. Renal Artery Stenting

When intervention is chosen for:

Atherosclerotic ostial renal artery stenosis,

angioplasty may be combined with:

Stent placement.

The purpose is to maintain vessel patency after dilation.

39. Surgical Revascularisation

Open surgical reconstruction is much less commonly required today.

It may be considered in selected patients with:

Complex vascular anatomy.

Concurrent aortic surgery.

Failed endovascular treatment.

40. Renovascular Disease – Note Form

Association:

Strongly associated with systemic atherosclerotic vascular disease.

Prognosis:

Often determined by high cardiovascular comorbidity.

Main presentation:

Hypertension.

Especially severe, resistant, abrupt, or worsening hypertension.

Important clue:

Recurrent flash pulmonary oedema.

Think bilateral severe renal artery stenosis.

Renal consequences:

AKI.

CKD.

Ischaemic nephropathy.

Occasionally ESKD.

ACE inhibitor clue:

Large creatinine rise after ACE inhibitor or ARB suggests bilateral renal artery stenosis or stenosis of a solitary functioning kidney.

Ultrasound:

May show asymmetrical renal size.

Duplex Doppler can assess renal artery blood flow.

Captopril renogram:

Historical test.

Now used much less often.

CTA/MRA:

Important non-invasive anatomical imaging.

Conventional angiography:

Invasive reference test, especially when intervention is contemplated.

Treatment:

Antihypertensive therapy.

Statin therapy.

Antiplatelet therapy when cardiovascular indications exist.

Smoking cessation.

Risk-factor modification.

Fibromuscular dysplasia:

Angioplasty is often effective.

Stent usually not routinely required.

Atherosclerotic stenosis:

Medical treatment is first-line in many patients.

Angioplasty/stenting reserved for selected high-risk presentations.

41. Important Corrections to the Original Notes

The original note lists:

“Angioplasty ± stenting”

as a general treatment.

This needs qualification.

For fibromuscular dysplasia, angioplasty is an important treatment.

For atherosclerotic renal artery stenosis, routine stenting is not indicated for every patient and is usually reserved for selected cases.

The original:

“Captopril renogram”

is now less commonly used.

Modern evaluation more often relies on:

Duplex Doppler ultrasound + CT angiography or MR angiography.

The older terms:

ARF, CRF and ESRF

are better replaced with:

AKI – acute kidney injury.

CKD – chronic kidney disease.

ESKD – end-stage kidney disease.

Key Clinical Pattern

Think of renovascular disease when there is:

SEVERE OR RESISTANT HYPERTENSION + GENERALIZED ATHEROSCLEROSIS.

A particularly important clue is:

FLASH PULMONARY OEDEMA + HYPERTENSION → THINK BILATERAL RENAL ARTERY STENOSIS.

Also remember:

ACEi/ARB → LARGE CREATININE RISE → THINK BILATERAL RENAL ARTERY STENOSIS OR STENOSIS OF A SOLITARY KIDNEY.

For causes:

OLDER + ATHEROSCLEROSIS → ATHEROSCLEROTIC RENAL ARTERY STENOSIS.

YOUNGER WOMAN + HYPERTENSION + STRING OF BEADS → FIBROMUSCULAR DYSPLASIA.

And for management:

ATHEROSCLEROTIC DISEASE → MEDICAL THERAPY FIRST IN MANY PATIENTS.

FIBROMUSCULAR DYSPLASIA → ANGIOPLASTY OFTEN EFFECTIVE.

Medicine – Diabetic Kidney Disease

Diabetic kidney disease, traditionally called diabetic nephropathy, is one of the most important microvascular complications of diabetes mellitus. It is characterised by persistent albuminuria, progressive loss of kidney function, and an increased risk of cardiovascular disease.

Diabetes remains one of the leading causes of end-stage kidney disease (ESKD) in many countries, including the UK.

1. Diabetes as a Cause of End-Stage Kidney Disease

Older teaching commonly states that diabetes is:

The most common cause of ESRF in the UK.

The modern term is:

End-stage kidney disease, or ESKD.

Diabetes remains a major cause of ESKD and renal replacement therapy because chronic hyperglycaemia causes progressive glomerular and vascular injury over many years.

2. Type 1 Diabetes and Nephropathy

The original note states that:

49% of patients with type 1 diabetes develop nephropathy after 20–40 years.

This is an older estimate and is probably too high for many modern cohorts because improved glycaemic control, blood-pressure management, and renoprotective therapy have reduced the incidence.

The key point remains:

The risk of diabetic kidney disease increases with duration of diabetes.

3. Risk Factors for Diabetic Kidney Disease

Important factors that increase the risk of diabetic kidney disease include:

Long duration of diabetes.

Poor glycaemic control.

Hypertension.

Smoking.

Dyslipidaemia.

Obesity.

Family or genetic susceptibility.

4. Pathophysiology

Chronic hyperglycaemia causes structural and functional changes in the glomerulus.

Early changes include:

Glomerular hyperfiltration.

Increased intraglomerular pressure.

Basement membrane thickening.

Mesangial expansion.

Over time, these changes lead to:

Albuminuria.

Glomerulosclerosis.

Progressive decline in GFR.

5. Glomerular Hyperfiltration

In early diabetes, the kidneys may show:

Increased GFR.

This is partly due to changes in afferent and efferent arteriolar tone that increase pressure within the glomerular capillaries.

Persistent:

Intraglomerular hypertension

contributes to progressive glomerular injury.

6. Albuminuria

One of the earliest clinically detectable abnormalities is:

Increased urinary albumin excretion.

Older terminology used:

Microalbuminuria.

Modern terminology generally prefers:

Moderately increased albuminuria.

7. Microalbuminuria – Older Definition

The original note gives:

30–250 mg/day.

Traditional definitions usually use approximately:

30–300 mg of albumin per day.

Therefore, 30–250 mg/day is slightly narrower than the standard older teaching range.

8. Modern Albuminuria Categories

Modern practice commonly uses the:

Urine albumin-to-creatinine ratio, or ACR.

Albuminuria is divided into:

A1 – Normal to mildly increased.

A2 – Moderately increased.

A3 – Severely increased.

This is preferred over the older terms microalbuminuria and macroalbuminuria.

9. Moderately Increased Albuminuria

Moderately increased albuminuria corresponds roughly to:

30–300 mg albumin/day

or an equivalent raised urinary ACR.

This stage may occur before a major fall in GFR.

10. Severely Increased Albuminuria

As disease progresses, albumin excretion may increase substantially.

Older notes may describe:

Proteinuria greater than 0.5 g/day.

However, modern assessment usually focuses on:

Albuminuria categories and urinary ACR

rather than a single total-protein threshold.

11. Persistent Albuminuria

A single abnormal urine test is not enough to diagnose diabetic kidney disease.

Albuminuria should generally be confirmed as:

Persistent

because temporary increases may occur with:

Exercise.

Fever.

UTI.

Marked hyperglycaemia.

Heart failure.

12. Hypertension

Hypertension commonly accompanies diabetic kidney disease.

It can be both:

A cause of faster renal progression

and

A consequence of worsening renal disease.

As nephropathy progresses:

Sodium retention + RAAS activation + vascular disease → worsening hypertension.

13. Nephrotic Syndrome

Advanced diabetic glomerular disease can produce:

Heavy proteinuria.

This may progress to:

Nephrotic syndrome.

Features include:

Marked proteinuria.

Hypoalbuminaemia.

Peripheral oedema.

Hyperlipidaemia.

14. Chronic Kidney Disease

Progressive diabetic kidney disease can cause:

Chronic kidney disease, or CKD.

The older term:

CRF – chronic renal failure

is now generally replaced by:

CKD.

As CKD advances, the patient may develop:

Reduced eGFR.

Anaemia.

Fluid retention.

Electrolyte disturbances.

Uraemic complications.

15. Progression of Diabetic Kidney Disease

A simplified classical sequence is:

Hyperfiltration → moderately increased albuminuria → overt proteinuria → declining GFR → CKD → ESKD.

However, modern understanding recognises that some patients can lose GFR without developing marked albuminuria.

Therefore, diabetic kidney disease is not always perfectly linear.

16. Renal Histology

Diabetic kidney disease causes characteristic structural changes within the glomeruli and renal vasculature.

Important findings include:

Glomerular basement membrane thickening.

Mesangial expansion.

Diffuse glomerulosclerosis.

Nodular glomerulosclerosis.

Arteriolar hyalinosis.

17. Kimmelstiel–Wilson Nodules

The classic biopsy finding is:

Kimmelstiel–Wilson nodules.

These represent:

Nodular mesangial expansion

and are characteristic of advanced diabetic glomerulosclerosis.

18. Nodular Glomerulosclerosis

Kimmelstiel–Wilson lesions are rounded areas of:

Mesangial matrix accumulation

within the glomerulus.

This pattern is also called:

Nodular diabetic glomerulosclerosis.

It is highly characteristic in the appropriate clinical setting, although nodular sclerosis is not absolutely unique to diabetes.

19. Diffuse Glomerulosclerosis

Before or alongside nodular lesions, diabetes may cause:

Diffuse mesangial expansion.

This produces progressive reduction in available glomerular capillary surface area.

Over time:

Glomerular filtration declines.

20. Arteriolar Hyalinosis

Diabetes commonly causes:

Hyaline arteriolosclerosis.

An important distinction from uncomplicated hypertension is that diabetes may affect both:

Afferent arterioles

and

Efferent arterioles.

This is a classic pathological clue.

21. When Kidney Biopsy Is Needed

Diabetic kidney disease is often diagnosed clinically rather than by biopsy.

Biopsy may be considered when features suggest another renal disease, for example:

Rapidly declining kidney function.

Active urinary sediment.

Marked haematuria.

Abrupt onset of heavy proteinuria.

Absence of other diabetic microvascular disease in a suspicious context.

22. Diabetic Retinopathy and Nephropathy

In type 1 diabetes, diabetic nephropathy often occurs alongside:

Diabetic retinopathy.

The absence of retinopathy in a patient with major proteinuria may increase suspicion of another renal diagnosis, particularly in type 1 diabetes.

In type 2 diabetes, the association is less consistent.

23. Treatment Principles

Management aims to slow loss of kidney function and reduce cardiovascular risk.

Important components include:

Good glycaemic control.

Blood-pressure control.

Reduction of albuminuria.

RAAS blockade where indicated.

SGLT2 inhibitor therapy in suitable patients.

Cardiovascular risk reduction.

24. ACE Inhibitors

ACE inhibitors are important in diabetic kidney disease, especially when there is:

Hypertension and albuminuria.

They reduce:

Systemic blood pressure

and

Intraglomerular pressure.

This decreases albuminuria and can slow renal progression.

25. Angiotensin II Receptor Blockers

Angiotensin II receptor blockers, or ARBs, provide similar renoprotective effects.

They are often used when:

ACE inhibitors are not tolerated.

26. Do Not Routinely Combine ACE Inhibitors and ARBs

An important modern correction is:

ACE inhibitors and ARBs should not routinely be used together.

Dual blockade increases the risk of:

Hyperkalaemia.

Acute kidney injury.

Hypotension.

without sufficient additional renal benefit.

Therefore:

ACE inhibitor OR ARB, not routinely both.

27. SGLT2 Inhibitors

A major modern addition is the use of:

SGLT2 inhibitors.

Examples include:

Empagliflozin.

Dapagliflozin.

Canagliflozin.

In appropriate patients, these drugs reduce:

Progression of CKD.

Albuminuria.

Heart-failure events.

They are now central renoprotective therapy in many patients with diabetic CKD.

28. How SGLT2 Inhibitors Protect the Kidney

SGLT2 inhibitors increase sodium delivery to the macula densa.

This helps restore:

Tubuloglomerular feedback

and reduces:

Intraglomerular pressure.

Therefore:

SGLT2 inhibition → reduced hyperfiltration → renal protection.

29. Glycaemic Control

Good glycaemic control reduces the development and progression of diabetic microvascular complications.

Therefore:

Tight or individualised glycaemic control

is an important part of preventing diabetic kidney disease.

However, targets should be individualised according to:

Age.

Comorbidity.

Hypoglycaemia risk.

Duration of diabetes.

Kidney function.

30. Blood-Pressure Control

Good blood-pressure control is essential because hypertension markedly accelerates progression of diabetic kidney disease.

The original target:

<130/75 mmHg

reflects older teaching.

Modern guidelines generally individualise targets rather than using 130/75 mmHg for every patient.

31. Modern Blood-Pressure Targets

In many patients with diabetic CKD and albuminuria, a target around:

<130/80 mmHg

may be considered if tolerated, though exact targets vary between guidelines and individual clinical circumstances.

The key principle is:

Avoid uncontrolled hypertension while preventing symptomatic hypotension or renal hypoperfusion.

32. Finerenone

Another modern therapy in selected patients with:

Type 2 diabetes + CKD + persistent albuminuria

despite appropriate ACE inhibitor or ARB therapy is:

Finerenone.

This is a:

Non-steroidal mineralocorticoid receptor antagonist.

It can reduce renal and cardiovascular events in suitable patients.

33. Lipid and Cardiovascular Risk Management

Patients with diabetic kidney disease have a high cardiovascular risk.

Management therefore also includes:

Statin therapy where indicated.

Smoking cessation.

Weight management.

Exercise as appropriate.

Management of other cardiovascular risk factors.

34. Monitoring

Patients should be monitored with:

Serum creatinine and eGFR.

Urinary ACR.

Serum potassium.

Blood pressure.

HbA1c.

Monitoring is especially important after starting or increasing:

ACE inhibitors.

ARBs.

SGLT2 inhibitors.

Mineralocorticoid receptor antagonists.

35. Diabetic Kidney Disease – Note Form

Importance:

Diabetes is one of the leading causes of ESKD.

Type 1 diabetes:

Risk increases with duration.

Older estimates of almost 50% developing nephropathy are higher than many modern cohorts.

Early renal change:

Glomerular hyperfiltration.

Early clinical marker:

Moderately increased albuminuria.

Older term:

Microalbuminuria.

Approximately 30–300 mg/day.

Progression:

Increasing albuminuria.

Hypertension.

Heavy proteinuria.

Nephrotic syndrome.

Declining GFR.

CKD.

ESKD.

Histology:

GBM thickening.

Mesangial expansion.

Diffuse glomerulosclerosis.

Kimmelstiel–Wilson nodules.

Afferent and efferent arteriolar hyalinosis.

Treatment:

Good glycaemic control.

Good blood-pressure control.

ACE inhibitor OR ARB where indicated.

SGLT2 inhibitor in appropriate patients.

Finerenone in selected type 2 diabetic CKD with persistent albuminuria.

Cardiovascular risk reduction.

36. Important Corrections to the Original Notes

The older term:

ESRF

is better replaced by:

ESKD – end-stage kidney disease.

The statement:

“49% of type 1 diabetics develop nephropathy after 20–40 years”

should not be treated as a fixed modern figure.

Risk varies greatly and has fallen with improved diabetes and blood-pressure management.

The older definition:

Microalbuminuria 30–250 mg/day

is better written as approximately:

30–300 mg albumin/day

or, preferably, assessed using:

Urinary albumin-to-creatinine ratio.

The treatment statement:

“ACE inhibitors and angiotensin II blockers”

should not imply combining them.

Remember:

ACE INHIBITOR OR ARB – NOT ROUTINE DUAL THERAPY.

The blood-pressure target:

<130/75 mmHg

is an older fixed target.

Modern care generally uses:

Individualised targets, often around <130/80 mmHg when appropriate and tolerated.

Key Clinical Pattern

Think:

DIABETES → GLOMERULAR HYPERFILTRATION → ALBUMINURIA → GLOMERULOSCLEROSIS → FALLING GFR → CKD / ESKD.

The classic pathology is:

KIMMELSTIEL–WILSON NODULES = NODULAR DIABETIC GLOMERULOSCLEROSIS.

Another high-yield pathology clue is:

DIABETES → HYALINOSIS OF BOTH AFFERENT AND EFFERENT ARTERIOLES.

For treatment remember:

GLYCAEMIC CONTROL + BLOOD-PRESSURE CONTROL + ACEi/ARB + SGLT2 INHIBITOR WHEN APPROPRIATE.

And:

DO NOT ROUTINELY COMBINE ACE INHIBITORS WITH ARBs.

Medicine – Hypertension and the Kidney

Hypertension and kidney disease have a bidirectional relationship. Chronic hypertension can damage the renal vasculature and glomeruli, while primary kidney disease can itself produce or worsen hypertension through sodium retention, volume expansion, and activation of the renin–angiotensin–aldosterone system.

The renal effects of hypertension depend particularly on the severity and duration of blood-pressure elevation and on whether chronic kidney disease, diabetes, vascular disease, or other renal pathology is already present.

1. Essential Hypertension and Renal Dysfunction

Older teaching states that:

Significant renal dysfunction is uncommon in uncomplicated essential hypertension.

This is useful but requires some qualification.

Mild-to-moderate hypertension can gradually contribute to chronic kidney damage, particularly when present for many years. However, marked or rapidly progressive renal impairment should not automatically be attributed to essential hypertension.

2. Significant Renal Dysfunction Should Prompt Investigation

When a patient with hypertension develops substantial renal impairment, other causes should be considered.

Important possibilities include:

Primary glomerular disease.

Diabetic kidney disease.

Renovascular disease.

Tubulointerstitial disease.

Obstructive uropathy.

Polycystic kidney disease.

Systemic inflammatory or autoimmune disease.

Therefore:

Hypertension + unexpectedly severe renal dysfunction → investigate for underlying kidney disease.

3. Hypertension Can Be a Cause or Consequence of Kidney Disease

The relationship works in both directions.

Hypertension → renal vascular and glomerular injury → declining kidney function.

At the same time:

Kidney disease → sodium retention + volume expansion + RAAS activation → hypertension.

This can create a vicious cycle in which hypertension and renal damage progressively worsen each other.

4. Renal Blood Flow in Chronic Hypertension

In chronic hypertension, structural changes develop within the renal microcirculation.

Renal vascular resistance increases and:

Renal blood flow may decrease.

Despite this, the kidney can initially preserve glomerular filtration through autoregulatory mechanisms.

Thus:

Renal blood flow ↓ while GFR may remain relatively preserved early in the disease.

5. Renal Autoregulation

The kidneys normally maintain relatively stable renal blood flow and GFR across a range of systemic blood pressures through:

Autoregulation.

The afferent arteriole adjusts its vascular tone to protect the glomerular capillaries from excessive systemic pressure.

With long-standing hypertension, however, structural vascular injury eventually develops and autoregulation becomes less effective.

6. Hyaline Arteriolosclerosis

The characteristic small-vessel lesion of long-standing hypertension is:

Hyaline arteriolosclerosis.

There is deposition of homogeneous eosinophilic hyaline material within the walls of small arteries and arterioles.

This causes:

Wall thickening.

Luminal narrowing.

Reduced renal perfusion.

7. Afferent Arteriolar Hyalinisation

The renal afferent arterioles are particularly affected.

Progressive arteriolar narrowing reduces blood supply to the downstream:

Glomeruli.

Tubules.

Renal interstitium.

This produces chronic renal ischaemia.

8. Benign Nephrosclerosis

The chronic renal changes associated with long-standing hypertension are traditionally called:

Benign hypertensive nephrosclerosis.

Despite the word “benign,” the process can contribute to progressive chronic kidney disease, particularly when hypertension is severe, prolonged, or accompanied by other renal risk factors.

9. Pathology of Chronic Hypertensive Nephrosclerosis

Typical pathological changes include:

Hyaline arteriolosclerosis.

Intimal and medial thickening of small arteries.

Narrowing of vascular lumina.

Chronic glomerular ischaemia.

Glomerulosclerosis.

Tubular atrophy.

Interstitial fibrosis.

10. Gross Appearance of the Kidney

With advanced chronic hypertensive nephrosclerosis, the kidneys may become:

Bilaterally small and contracted.

The renal surface may show:

Fine granularity.

This reflects widespread chronic vascular, glomerular, tubular, and interstitial damage.

11. Glomerulosclerosis

Persistent renal ischaemia eventually causes glomerular injury and scarring.

This produces:

Glomerulosclerosis.

As functioning nephrons are progressively lost, GFR declines and chronic kidney disease may develop.

12. Tubular Atrophy and Interstitial Fibrosis

Reduced blood supply also damages the renal tubules and interstitium.

Chronic injury produces:

Tubular atrophy

and

Interstitial fibrosis.

These are important histological markers of chronic irreversible kidney damage.

13. Ageing and Renal Function

Renal function tends to decline gradually with ageing, although the degree of decline varies greatly between individuals.

Age-related renal changes may include:

Loss of functioning nephrons.

Glomerulosclerosis.

Vascular sclerosis.

Reduced renal blood flow.

14. Hypertension and Ageing

Hypertension can accelerate age-related renal vascular damage.

Older individuals are also more likely to have:

Atherosclerosis.

Arteriosclerosis.

Diabetes.

Other cardiovascular disease.

These conditions may combine to produce progressive loss of renal function.

15. Atherosclerosis versus Arteriolosclerosis

These terms should not be confused.

Atherosclerosis primarily affects larger and medium-sized arteries through lipid-rich plaques.

Arteriolosclerosis affects small arteries and arterioles.

In chronic hypertension, an important renal lesion is:

Hyaline arteriolosclerosis.

Both processes may coexist, particularly in older patients.

16. Hypertension in Chronic Kidney Disease

Hypertension is extremely common in:

Chronic kidney disease, or CKD.

As kidney function declines, impaired sodium excretion contributes to:

Sodium retention.

Water retention.

Extracellular volume expansion.

This promotes hypertension.

17. RAAS Activation in Kidney Disease

Some forms of renal disease also cause activation of the:

Renin–angiotensin–aldosterone system.

The result may be:

Vasoconstriction.

Sodium retention.

Further elevation of blood pressure.

Therefore, renal disease can strongly drive hypertension.

18. Uncontrolled Hypertension Accelerates CKD

The original statement that:

“Uncontrolled hypertension in CRF accelerates loss of renal function”

remains an important principle.

The modern term:

Chronic kidney disease (CKD)

is preferred to the older term chronic renal failure (CRF).

19. Vicious Cycle of Hypertension and CKD

The relationship can be remembered as:

CKD → hypertension → further renal damage → worsening CKD → worsening hypertension.

Breaking this cycle through effective blood-pressure control is a major goal of CKD management.

20. Glomerular Hypertension

Systemic hypertension can increase pressure within the glomerular capillaries, particularly when renal autoregulation is impaired.

Persistent:

Intraglomerular hypertension

can damage the filtration barrier and promote:

Proteinuria.

Glomerulosclerosis.

Progressive nephron loss.

21. Proteinuria

Proteinuria is not simply a marker of kidney disease.

Persistent protein filtration can itself contribute to:

Tubulointerstitial inflammation and fibrosis.

Therefore, reducing both:

Blood pressure

and

Proteinuria

is important in slowing progression of many forms of CKD.

22. ACE Inhibitors and ARBs

In appropriate patients, particularly those with albuminuric CKD, blockade of the renin–angiotensin system using:

ACE inhibitors

or

Angiotensin II receptor blockers (ARBs)

can reduce:

Systemic blood pressure.

Intraglomerular pressure.

Proteinuria or albuminuria.

This can slow progression of kidney disease in suitable patients.

23. Severe Hypertension and Acute Renal Injury

Very severe hypertension can cause acute target-organ damage, including acute renal injury.

Older terminology described this as:

Accelerated or malignant hypertension.

Modern clinical terminology commonly uses:

Hypertensive emergency

when severe hypertension is accompanied by acute target-organ injury.

24. Malignant Nephrosclerosis

The severe renal vascular injury associated with a hypertensive emergency is traditionally called:

Malignant nephrosclerosis.

This is different from the slower vascular damage seen in chronic hypertension.

25. Fibrinoid Necrosis

One of the characteristic histological findings in severe hypertensive vascular injury is:

Fibrinoid necrosis of arterioles.

The vessel wall undergoes acute injury with deposition of fibrin-like material.

This can severely compromise renal perfusion.

26. Hyperplastic Arteriolosclerosis

Another characteristic lesion of severe hypertension is:

Hyperplastic arteriolosclerosis.

There is concentric proliferation and thickening of the arteriolar wall.

This produces an:

“Onion-skin” appearance.

The vessel lumen becomes markedly narrowed.

27. Important Distinction from Scleroderma Renal Crisis

The onion-skin vascular pattern can also occur in:

Scleroderma renal crisis.

Therefore, onion-skin arteriolar narrowing is not specific to systemic sclerosis.

Both severe hypertension and scleroderma renal crisis can produce marked small-vessel injury.

28. Acute Kidney Injury in Severe Hypertension

Severe narrowing and injury of the renal vasculature can cause:

Renal ischaemia.

This may produce:

Acute kidney injury.

The older term:

Acute renal failure (ARF)

is now generally replaced by:

Acute kidney injury (AKI).

29. Severe Tubular and Glomerular Ischaemia

Marked reduction in renal perfusion can cause:

Glomerular ischaemia.

Tubular ischaemia and injury.

Renal function may deteriorate rapidly.

Thus severe hypertension can produce both:

Vascular injury

and

Secondary ischaemic parenchymal damage.

30. Microangiopathic Haemolytic Anaemia

Severe hypertensive vascular injury may also damage circulating red blood cells as they pass through narrowed small vessels.

This can produce:

Microangiopathic haemolytic anaemia (MAHA).

Possible findings include:

Schistocytes.

Raised LDH.

Reduced haptoglobin.

Thrombocytopenia may occur.

31. Chronic Kidney Disease Histology

When hypertension contributes to long-standing renal damage, biopsy may demonstrate:

Glomerulosclerosis.

Tubular atrophy.

Interstitial fibrosis.

Arterial and arteriolar sclerosis.

These findings represent chronic structural damage.

32. Histology in Chronic Hypertension – Note Form

Small arteries and arterioles:

Hyaline arteriolosclerosis.

Intimal thickening.

Luminal narrowing.

Glomeruli:

Chronic ischaemia.

Glomerulosclerosis.

Tubules:

Tubular atrophy.

Interstitium:

Interstitial fibrosis.

33. Histology in Severe or Accelerated Hypertension – Note Form

Arterioles:

Fibrinoid necrosis.

Small vessels:

Hyperplastic arteriolosclerosis.

Concentric onion-skin thickening.

Renal parenchyma:

Severe glomerular and tubular ischaemia.

Clinical consequence:

Acute kidney injury may develop.

34. Hypertension and the Kidney – Note Form

Uncomplicated essential hypertension:

Severe renal dysfunction should not automatically be attributed to hypertension.

Look for primary or secondary kidney disease if renal impairment is unexpectedly marked.

Renal blood flow:

May decrease with chronic hypertension.

GFR may initially remain relatively preserved through autoregulation.

Chronic vascular lesion:

Hyaline arteriolosclerosis.

Particularly affects small renal arteries and afferent arterioles.

Consequence:

Luminal narrowing → chronic renal ischaemia → glomerulosclerosis + tubular atrophy + interstitial fibrosis.

Ageing:

Associated with gradual nephron loss, vascular sclerosis and glomerulosclerosis.

Hypertension and atherosclerotic vascular disease may accelerate renal decline.

CKD:

Uncontrolled hypertension accelerates loss of renal function.

Kidney disease itself also promotes hypertension.

Severe hypertension:

May cause fibrinoid necrosis and hyperplastic arteriolosclerosis.

Can result in acute kidney injury.

35. Important Corrections to the Original Notes

The statement:

“Significant renal dysfunction in uncomplicated essential hypertension is rare”

should not be interpreted as meaning hypertension cannot cause CKD.

Long-standing hypertension can contribute to chronic kidney damage, but severe, rapid, or disproportionate renal dysfunction should prompt investigation for another or additional renal disease.

The older terms:

ARF

and

CRF

are now better written as:

AKI – Acute Kidney Injury

and

CKD – Chronic Kidney Disease.

The original biopsy description:

“Arterial fibrinoid necrosis in accelerated hypertension”

is broadly correct, but another important lesion is:

Hyperplastic arteriolosclerosis with onion-skin thickening.

Key Clinical Pattern

The relationship is:

HYPERTENSION → RENAL VASCULAR DAMAGE → ISCHAEMIA → GLOMERULOSCLEROSIS → CKD.

At the same time:

CKD → SODIUM RETENTION + RAAS ACTIVATION → HYPERTENSION.

Therefore:

HYPERTENSION ↔ CKD

can form a progressive vicious cycle.

For pathology, remember:

CHRONIC HYPERTENSION → HYALINE ARTERIOLOSCLEROSIS + GLOMERULOSCLEROSIS + INTERSTITIAL FIBROSIS.

SEVERE / ACCELERATED HYPERTENSION → FIBRINOID NECROSIS + HYPERPLASTIC “ONION-SKIN” ARTERIOLOSCLEROSIS + AKI.

And clinically:

HYPERTENSION + SEVERE OR RAPIDLY PROGRESSIVE RENAL IMPAIRMENT → DO NOT SIMPLY ASSUME ESSENTIAL HYPERTENSION; LOOK FOR UNDERLYING RENAL DISEASE.

Medicine – Lupus Nephritis in Systemic Lupus Erythematosus

Lupus nephritis is renal involvement caused by systemic lupus erythematosus (SLE). It results primarily from immune-complex deposition and complement activation within the kidneys, producing inflammation and damage involving the glomeruli and, in some patients, the tubulointerstitial and vascular compartments.

Renal involvement is one of the most important manifestations of SLE because severe lupus nephritis can lead to acute kidney injury, chronic kidney disease, and eventually kidney failure.

1. Frequency of Renal Involvement

The original figure of approximately:

40% of patients with SLE

developing renal involvement is a reasonable traditional estimate for clinically apparent lupus nephritis in adults, although the exact frequency varies according to the population studied and the definition used.

Renal involvement is generally more frequent and may be more severe in certain younger and non-European ancestry populations.

2. Lupus Nephritis May Have Many Presentations

An important characteristic of lupus nephritis is that:

Almost any glomerular pattern of renal disease may occur.

The clinical presentation can range from mild urinary abnormalities to rapidly progressive kidney dysfunction.

3. Possible Clinical Presentations

Lupus nephritis may present with:

Asymptomatic proteinuria.

Microscopic haematuria.

Active urinary sediment.

Nephritic syndrome.

Nephrotic syndrome.

Hypertension.

Acute kidney injury.

Progressive chronic kidney disease.

Therefore, significant lupus nephritis may occasionally be detected through routine urine testing before major renal symptoms develop.

4. Proteinuria

Proteinuria is one of the most important manifestations of lupus nephritis.

The amount may range from relatively mild protein loss to:

Nephrotic-range proteinuria.

When severe, the patient may develop:

Hypoalbuminaemia.

Peripheral oedema.

Hyperlipidaemia.

This produces a nephrotic syndrome.

5. Haematuria and Active Urinary Sediment

Glomerular inflammation can cause:

Microscopic haematuria.

Urine microscopy may demonstrate:

Dysmorphic red blood cells.

Red-cell casts.

White-cell casts.

The combination of proteinuria, haematuria, and cellular casts suggests active glomerular inflammation.

6. Nephritic Syndrome

Proliferative forms of lupus nephritis may produce a:

Nephritic syndrome.

Typical features include:

Haematuria.

Proteinuria.

Hypertension.

Reduced renal function.

Oedema.

An active urinary sediment is particularly characteristic.

7. Nephrotic Syndrome

Some forms of lupus nephritis may produce:

Nephrotic syndrome.

This is particularly associated with:

Class V membranous lupus nephritis,

although proliferative disease can also cause heavy proteinuria.

8. Acute Kidney Injury

Severe lupus nephritis can cause rapidly deteriorating kidney function and:

Acute kidney injury (AKI).

The older term:

Acute renal failure, or ARF,

has largely been replaced by acute kidney injury.

AKI in a patient with SLE requires prompt assessment because active proliferative lupus nephritis may require intensive immunosuppressive treatment.

9. Pathogenesis

SLE is characterised by loss of immune tolerance and production of:

Autoantibodies.

Immune complexes can form and become deposited within renal structures.

This activates:

Complement.

Inflammatory cells.

Cytokine pathways.

The resulting inflammation damages the glomerular filtration barrier and other renal structures.

10. Anti-Double-Stranded DNA Antibodies

An important antibody associated with lupus nephritis is:

Anti-double-stranded DNA, or anti-dsDNA.

Rising anti-dsDNA titres may accompany increased lupus activity in some patients, particularly renal disease.

However, antibody titres must always be interpreted alongside the patient’s clinical findings.

11. Complement Levels

Active lupus nephritis may be associated with consumption of complement.

Therefore:

C3 ↓

and

C4 ↓

may support active immune-complex disease.

A useful clinical pattern is:

Increasing anti-dsDNA + falling complement + increasing proteinuria/active urine sediment → consider active lupus nephritis.

However, none of these markers alone determines renal activity with complete accuracy.

12. Histology Is Variable

The original statement:

“Histology variable”

is important.

Lupus nephritis can produce several different histological patterns.

For this reason, renal biopsy is often central to determining:

The class of lupus nephritis.

The degree of active inflammation.

The amount of chronic irreversible damage.

The appropriate treatment strategy.

13. Classification of Lupus Nephritis

Lupus nephritis is traditionally divided into six major pathological classes:

Class I – Minimal mesangial lupus nephritis.

Class II – Mesangial proliferative lupus nephritis.

Class III – Focal lupus nephritis.

Class IV – Diffuse lupus nephritis.

Class V – Membranous lupus nephritis.

Class VI – Advanced sclerosing lupus nephritis.

This classification is based primarily on kidney biopsy findings.

14. Class I – Minimal Mesangial Lupus Nephritis

In Class I, the glomeruli may appear essentially normal on conventional light microscopy.

However, immunofluorescence or electron microscopy demonstrates:

Mesangial immune deposits.

Clinical renal disease is usually minimal.

15. Class II – Mesangial Proliferative Lupus Nephritis

Class II is characterised by:

Mesangial hypercellularity

and

Mesangial immune-complex deposition.

Patients may have:

Mild proteinuria.

Microscopic haematuria.

Renal function is usually relatively preserved.

16. Class III – Focal Lupus Nephritis

Class III involves active or chronic lesions affecting:

Less than 50% of glomeruli.

Patients may develop:

Haematuria.

Proteinuria.

Hypertension.

Reduced kidney function.

It represents an important proliferative form of lupus nephritis.

17. Class IV – Diffuse Lupus Nephritis

Class IV diffuse lupus nephritis involves:

50% or more of glomeruli.

It is one of the most severe and clinically important forms.

Patients may develop:

Nephritic syndrome.

Heavy proteinuria.

Hypertension.

Active urinary sediment.

Acute kidney injury.

Without appropriate treatment, significant permanent renal damage can occur.

18. Class V – Membranous Lupus Nephritis

Class V is characterised predominantly by a membranous pattern of glomerular injury.

It commonly presents with:

Heavy proteinuria

and may produce:

Nephrotic syndrome.

Class V disease may occur alone or together with proliferative Class III or IV disease.

19. Class VI – Advanced Sclerosing Lupus Nephritis

Class VI represents advanced chronic irreversible glomerular damage.

There is extensive:

Glomerulosclerosis.

At this stage, aggressive immunosuppression directed at active inflammation generally provides little benefit when damage is predominantly irreversible.

Management focuses on chronic kidney disease and kidney failure care.

20. “Full-House” Immunofluorescence

A classic pathological feature of lupus nephritis is:

“Full-house” immunofluorescence.

This refers to deposition of multiple immunoglobulins and complement components, classically including:

IgG.

IgA.

IgM.

C3.

C1q.

This pattern strongly supports lupus nephritis in the appropriate clinical setting.

21. Renal Biopsy

A kidney biopsy is commonly considered when there is evidence suggesting clinically significant lupus nephritis, such as substantial proteinuria, active urinary sediment, or otherwise unexplained impairment of renal function.

The biopsy helps distinguish:

Active potentially reversible inflammation

from

Chronic irreversible scarring.

This distinction strongly influences treatment.

22. Treatment Principles

Treatment depends on:

Histological class.

Disease activity.

Severity of proteinuria.

Renal function.

Extrarenal SLE activity.

Modern management is therefore more specific than simply treating every patient with renal SLE using the same immunosuppressive regimen.

23. Induction Therapy

Severe active lupus nephritis, particularly:

Class III

and

Class IV

with or without Class V disease, generally requires an initial intensive phase called:

Induction therapy.

The purpose is to rapidly suppress renal inflammation and prevent irreversible nephron loss.

24. Glucocorticoids

Glucocorticoids remain an important component of treatment for active proliferative lupus nephritis.

Depending on severity, treatment may begin with:

Intravenous methylprednisolone pulses

followed by:

Oral glucocorticoids with subsequent dose reduction.

Modern treatment generally aims to minimise cumulative steroid exposure because of substantial long-term toxicity.

25. Mycophenolate

Mycophenolate mofetil, or related mycophenolic acid therapy, is a major modern treatment for lupus nephritis.

It may be used as part of:

Induction therapy

and

Maintenance therapy.

It is particularly important in proliferative lupus nephritis.

26. Cyclophosphamide

Cyclophosphamide is another major immunosuppressive treatment for severe proliferative lupus nephritis.

It may be particularly considered in patients with:

Severe Class III or IV disease.

Rapidly deteriorating renal function.

High-risk histological features.

The choice between cyclophosphamide- and mycophenolate-based regimens depends on the individual clinical situation.

27. Modern Combination Therapy

Current treatment has moved beyond the older model of simply giving high-dose steroids followed by azathioprine.

Depending on the patient and disease pattern, treatment may incorporate:

Mycophenolate.

Cyclophosphamide.

Belimumab.

Calcineurin-inhibitor-based therapy such as voclosporin or tacrolimus.

These are generally combined with glucocorticoids and background SLE therapy as appropriate.

28. Maintenance Therapy

Once active disease has been controlled, treatment enters the:

Maintenance phase.

The objective is to:

Prevent renal relapse.

Preserve kidney function.

Reduce cumulative treatment toxicity.

29. Maintenance Immunosuppression

Modern maintenance therapy commonly uses:

Mycophenolate

or

Azathioprine.

Therefore, the original statement that maintenance consists of:

“Oral steroids and azathioprine”

is incomplete.

Azathioprine remains useful, particularly in certain circumstances such as when pregnancy compatibility is important, but mycophenolate is widely used outside pregnancy.

30. Hydroxychloroquine

Unless contraindicated, hydroxychloroquine is an important background treatment for most patients with SLE, including those with lupus nephritis.

It helps reduce:

SLE disease activity.

Disease flares.

It is generally continued alongside renal-specific immunosuppressive therapy, with appropriate ophthalmological monitoring.

31. Control of Proteinuria and Blood Pressure

Renal protection is not achieved by immunosuppression alone.

Patients with hypertension and proteinuria may benefit from appropriate blockade of the:

Renin–angiotensin system

using an:

ACE inhibitor

or

Angiotensin receptor blocker,

when clinically appropriate.

This helps reduce:

Blood pressure

and

Proteinuria.

32. Plasma Exchange

The original note lists:

Plasma exchange.

However, plasma exchange is not routine standard treatment for ordinary lupus nephritis.

It has not demonstrated sufficient benefit to justify routine use simply because a patient has active lupus nephritis.

33. When Plasma Exchange May Be Considered

Plasma exchange may be considered in selected exceptional situations, particularly when SLE overlaps with another condition for which plasma exchange has a specific indication.

Examples may include selected cases involving:

Thrombotic thrombocytopenic purpura.

Severe thrombotic microangiopathy.

Anti-GBM disease.

Other specialised life-threatening situations may require individual consideration.

Therefore:

Lupus nephritis alone ≠ routine plasma exchange.

34. Monitoring Lupus Nephritis

Patients require regular monitoring of:

Serum creatinine and eGFR.

Urinalysis.

Urinary protein excretion.

Blood pressure.

Serum complement levels.

Anti-dsDNA antibodies.

Blood counts.

Monitoring helps assess response to therapy and identify relapse.

35. Prognosis

The prognosis of lupus nephritis has improved substantially with modern immunosuppressive and supportive therapy.

However, recurrent or inadequately controlled disease can lead to:

Chronic glomerular scarring.

Chronic kidney disease.

End-stage kidney disease.

Early recognition and effective suppression of active inflammation are therefore important.

36. Lupus Nephritis – Note Form

Frequency:

Clinically significant renal involvement occurs in a substantial proportion of patients with SLE, traditionally around 40% of adults.

Presentation:

Any glomerular presentation is possible.

Proteinuria.

Microscopic haematuria.

Active urinary sediment.

Nephritic syndrome.

Nephrotic syndrome.

Hypertension.

Acute kidney injury.

Chronic kidney disease.

Serology suggesting activity:

Anti-dsDNA may rise.

C3 and C4 may fall.

Histology:

Highly variable.

Kidney biopsy determines the pathological class and assesses activity versus chronicity.

Class I:

Minimal mesangial.

Class II:

Mesangial proliferative.

Class III:

Focal lupus nephritis.

Less than 50% of glomeruli involved.

Class IV:

Diffuse lupus nephritis.

50% or more of glomeruli involved.

Often severe proliferative renal disease.

Class V:

Membranous lupus nephritis.

Often associated with heavy proteinuria and nephrotic syndrome.

Class VI:

Advanced sclerosing lupus nephritis.

Predominantly irreversible chronic damage.

Classic immunofluorescence:

“Full-house” pattern.

IgG + IgA + IgM + C3 + C1q.

Severe active proliferative disease:

Glucocorticoids plus appropriate immunosuppression.

Mycophenolate or cyclophosphamide are major induction options, with newer combination approaches increasingly used.

Maintenance:

Mycophenolate or azathioprine depending on the clinical situation.

Glucocorticoids are reduced to the lowest appropriate exposure rather than automatically maintained at substantial doses indefinitely.

Plasma exchange:

Not routine treatment for uncomplicated lupus nephritis.

Reserved for selected overlapping or exceptional indications.

37. Important Corrections to the Original Notes

The original:

“ARF and SLE → aggressive immunosuppressant therapy”

is broadly correct for severe active lupus nephritis, but treatment should be guided by the clinical picture and renal biopsy whenever appropriate.

The modern term is:

Acute kidney injury rather than acute renal failure.

The original:

“Maintenance with oral steroids and azathioprine”

reflects older treatment practice.

Modern maintenance commonly uses:

Mycophenolate or azathioprine, while attempting to minimise long-term glucocorticoid exposure.

The original:

“Plasma exchange”

should not be memorised as routine lupus nephritis therapy.

Instead remember:

PLASMA EXCHANGE IS NOT ROUTINE FOR LUPUS NEPHRITIS ALONE.

Key Clinical Pattern

Think:

SLE + PROTEINURIA + HAEMATURIA + CELLULAR CASTS ± FALLING RENAL FUNCTION → LUPUS NEPHRITIS.

Disease activity may be accompanied by:

↑ ANTI-dsDNA + ↓ C3/C4.

The most important severe forms are:

CLASS III = FOCAL PROLIFERATIVE.

CLASS IV = DIFFUSE PROLIFERATIVE.

Class IV is particularly important because it can cause severe nephritic disease and rapidly deteriorating kidney function.

For nephrotic presentation, remember:

CLASS V = MEMBRANOUS → HEAVY PROTEINURIA / NEPHROTIC SYNDROME.

And the classic pathology clue is:

LUPUS NEPHRITIS → “FULL-HOUSE” IMMUNOFLUORESCENCE.

Medicine – Systemic Sclerosis and Scleroderma Renal Crisis

Systemic sclerosis is a chronic autoimmune connective tissue disease characterised by vascular dysfunction, immune activation, and progressive fibrosis affecting the skin and multiple internal organs.

Renal involvement is particularly important because systemic sclerosis can cause scleroderma renal crisis, a medical emergency associated with abrupt severe hypertension, acute kidney injury, and microangiopathic haemolytic anaemia.

1. Scleroderma Renal Crisis

The renal presentation described in the original note refers specifically to:

Scleroderma renal crisis.

This is one of the most serious complications of systemic sclerosis.

It typically presents with:

Sudden severe hypertension.

Rapidly rising creatinine.

Acute kidney injury.

Microangiopathic haemolytic anaemia.

2. Accelerated or Malignant Hypertension

Patients may develop:

Abrupt severe hypertension.

Older terminology often refers to:

Accelerated hypertension

or

Malignant hypertension.

Modern terminology generally prefers:

Hypertensive emergency

when severe blood pressure elevation is accompanied by acute target-organ damage.

3. Clinical Consequences of Severe Hypertension

Severe hypertension may produce:

Headache.

Visual disturbance.

Confusion.

Seizures.

Heart failure.

Pulmonary oedema.

Hypertensive retinopathy.

The kidney itself is one of the major target organs.

4. Acute Kidney Injury

Scleroderma renal crisis causes:

Rapid deterioration in renal function.

The older abbreviation:

ARF – acute renal failure

is now more commonly replaced by:

AKI – acute kidney injury.

Laboratory findings typically include a rapidly increasing:

Serum creatinine.

5. Microangiopathic Haemolytic Anaemia

A classic associated feature is:

Microangiopathic haemolytic anaemia, or MAHA.

This results from red blood cells being mechanically damaged while passing through narrowed small vessels.

6. Blood Film Findings

MAHA may produce:

Schistocytes.

These are fragmented red blood cells seen on the peripheral blood film.

Other laboratory findings may include:

Raised LDH.

Reduced haptoglobin.

Raised indirect bilirubin.

Reticulocytosis.

7. Thrombocytopenia

Platelets may also be consumed in the damaged microvasculature.

Therefore, some patients develop:

Thrombocytopenia.

This can make the presentation resemble other thrombotic microangiopathies.

8. Pathophysiology

The fundamental abnormality is severe injury and narrowing of the renal small vessels.

This leads to:

Reduced renal perfusion.

The kidney interprets this as inadequate effective circulation and activates the:

Renin–angiotensin–aldosterone system.

9. Renin Activation

The sequence is:

Renal vascular narrowing → renal ischaemia → renin release → angiotensin II formation → vasoconstriction → aldosterone release → further hypertension.

This creates a vicious cycle of:

Ischaemia + renin activation + worsening hypertension + further vascular damage.

10. Histology

The classic renal histological finding is:

Concentric intimal proliferation of small renal arteries and arterioles.

This produces the characteristic:

“Onion-skin” appearance.

11. Onion-Skin Lesions

The onion-skin appearance reflects:

Concentric thickening of vessel walls.

The lumen becomes markedly narrowed.

This reduces renal blood flow and contributes to:

Renal ischaemia.

Renin release.

Severe hypertension.

12. Interlobular Arteries and Arterioles

The vascular changes particularly affect:

Interlobular arteries

and

Arterioles.

Other changes may include:

Intimal proliferation.

Fibrinoid necrosis in severe cases.

Thrombotic microangiopathic changes.

13. Association with Diffuse Cutaneous Systemic Sclerosis

Scleroderma renal crisis is particularly associated with:

Diffuse cutaneous systemic sclerosis.

Risk is greatest relatively early in the disease course, often within the first few years.

14. Risk Factors

Important risk factors include:

Diffuse skin involvement.

Rapid progression of skin thickening.

Early disease.

Anti-RNA polymerase III antibodies.

Glucocorticoid exposure, especially higher doses.

15. Glucocorticoids

One particularly important association is:

High-dose corticosteroid therapy.

This may increase the risk of scleroderma renal crisis.

Therefore, systemic corticosteroids are used cautiously in systemic sclerosis and, when required for another indication, the lowest appropriate dose is preferred.

16. Anti-RNA Polymerase III

Anti-RNA polymerase III antibodies are strongly associated with:

Diffuse systemic sclerosis

and

Increased risk of scleroderma renal crisis.

This is an important modern addition to older teaching.

17. Treatment

The most important treatment is immediate:

ACE inhibitor therapy.

This should be started promptly when scleroderma renal crisis is suspected.

18. Why ACE Inhibitors Work

ACE inhibitors suppress the overactive:

Renin–angiotensin system.

They reduce:

Angiotensin II-mediated vasoconstriction

and

Aldosterone-mediated sodium retention.

This directly targets one of the central mechanisms driving the crisis.

19. Preferred ACE Inhibitor

A short-acting ACE inhibitor such as:

Captopril

has traditionally been used because it can be titrated rapidly.

Other ACE inhibitors may also be used depending on clinical circumstances and local practice.

20. ACE Inhibitors Should Not Be Withheld Because Creatinine Rises

A particularly important clinical principle is that ACE inhibitors are usually continued despite an initial rise in:

Serum creatinine.

In many other renal conditions, rising creatinine may prompt concern about ACE inhibition.

In scleroderma renal crisis, however, ACE inhibition is central to treatment.

21. Blood Pressure Control

Blood pressure should be lowered carefully but effectively.

The aim is to control:

Severe hypertension

while maintaining adequate organ perfusion.

Additional antihypertensive agents may be required if ACE inhibition alone is insufficient.

22. Dialysis

Some patients develop severe acute kidney injury requiring:

Dialysis.

Indications are the usual severe AKI indications, such as:

Refractory hyperkalaemia.

Severe metabolic acidosis.

Pulmonary oedema.

Uraemic complications.

23. Renal Recovery Can Occur

An important correction to older teaching is that dialysis dependence does not always mean permanent end-stage kidney disease.

Some patients may recover sufficient renal function:

Months after the acute crisis.

Therefore, kidney transplantation is usually not considered immediately after the crisis if recovery remains possible.

24. End-Stage Kidney Disease

Older notes often state:

“Many progress to ESRF.”

This was more accurate before ACE inhibitors became standard treatment.

ACE inhibitor therapy has dramatically improved renal survival and overall prognosis.

Some patients still develop:

End-stage kidney disease

but progression is no longer inevitable.

The preferred modern term is:

End-stage kidney disease, ESKD

rather than ESRF.

25. Kidney Transplantation

If irreversible kidney failure persists, selected patients may eventually undergo:

Kidney transplantation.

Timing depends on:

Duration of dialysis dependence.

Evidence of renal recovery.

Overall systemic sclerosis activity.

Cardiopulmonary status.

26. Systemic Sclerosis Beyond the Kidney

Systemic sclerosis is a multisystem disease.

Other important manifestations include:

Raynaud phenomenon.

Skin thickening and sclerodactyly.

Digital ulcers.

Oesophageal dysmotility and reflux.

Interstitial lung disease.

Pulmonary arterial hypertension.

Cardiac involvement.

27. Diffuse versus Limited Disease

Diffuse cutaneous systemic sclerosis tends to involve more proximal skin and has a higher risk of:

Renal crisis.

Interstitial lung disease.

Cardiac involvement.

Limited cutaneous systemic sclerosis tends to involve distal skin and is classically associated with:

CREST features

and later:

Pulmonary arterial hypertension.

28. Scleroderma Renal Crisis – Note Form

Presentation:

Abrupt severe hypertension.

Acute kidney injury.

Microangiopathic haemolytic anaemia.

Possible thrombocytopenia.

Histology:

Concentric intimal proliferation.

Onion-skin narrowing of interlobular arteries and arterioles.

Mechanism:

Renal vascular injury → renal ischaemia → renin release → severe hypertension.

Risk factors:

Diffuse cutaneous systemic sclerosis.

Early disease.

Rapidly progressive skin thickening.

Anti-RNA polymerase III antibodies.

Higher-dose corticosteroid exposure.

Treatment:

Immediate ACE inhibitor.

Captopril commonly used for rapid titration.

Dialysis if required.

Prognosis:

ACE inhibitors have markedly improved outcomes.

Some patients require dialysis temporarily.

Some progress to permanent end-stage kidney disease.

29. Important Corrections to the Original Notes

The original heading “Systemic sclerosis” is too broad for the renal findings listed.

The specific syndrome is:

Scleroderma renal crisis.

The older term:

Acute renal failure

is better replaced by:

Acute kidney injury.

The statement:

“Many progress to ESRF”

reflects older pre-ACE-inhibitor experience.

Modern treatment with ACE inhibitors has significantly improved renal outcomes, and some dialysis-dependent patients later recover kidney function.

Key Clinical Pattern

Think of scleroderma renal crisis as:

SYSTEMIC SCLEROSIS + SUDDEN SEVERE HYPERTENSION + AKI + MAHA.

The pathology is:

RENAL SMALL-VESSEL NARROWING → “ONION-SKIN” APPEARANCE → RENAL ISCHAEMIA → ↑ RENIN → SEVERE HYPERTENSION.

The treatment to remember is:

ACE INHIBITOR IMMEDIATELY.

And a particularly high-yield association is:

DIFFUSE SYSTEMIC SCLEROSIS + ANTI-RNA POLYMERASE III + HIGH-DOSE STEROIDS → INCREASED RISK OF RENAL CRISIS.

Medicine – Tumours of the Renal Tract

Tumours of the renal tract include benign renal tumours, renal cell carcinoma, Wilms tumour, and urothelial carcinoma. They differ considerably in their age of presentation, tissue of origin, risk factors, clinical manifestations, and associated syndromes.

An important distinction is between renal parenchymal tumours, such as renal cell carcinoma, and urothelial tumours, which arise from the lining of the renal pelvis, ureter, or bladder.

1. Benign Renal Tumours

Several benign tumours can arise within the kidney.

Important examples include:

Renal adenoma.

Angiomyolipoma.

Reninoma, or juxtaglomerular cell tumour.

Many benign renal masses are discovered incidentally during imaging performed for another reason.

2. Renal Adenoma

A renal adenoma is a small benign epithelial tumour of the kidney.

These lesions are often:

Asymptomatic.

Small.

Incidentally discovered.

Some renal adenomas can be difficult to distinguish histologically and radiologically from small malignant renal epithelial tumours.

3. Angiomyolipoma

The classic renal tumour traditionally described as a hamartomatous lesion is:

Angiomyolipoma.

It contains varying amounts of:

Blood vessels.

Smooth muscle.

Adipose tissue.

4. Angiomyolipoma and Tuberous Sclerosis

Renal angiomyolipomas have an important association with:

Tuberous sclerosis complex.

In tuberous sclerosis, they are more likely to be:

Multiple.

Bilateral.

Larger.

Larger lesions have an increased risk of spontaneous haemorrhage.

5. Juxtaglomerular Cell Tumour

A rare renin-producing renal tumour is the:

Juxtaglomerular cell tumour.

It is also called:

Reninoma.

This tumour secretes excessive:

Renin.

6. Reninoma and Hypertension

Excessive renin activates the:

Renin–angiotensin–aldosterone system.

This produces:

↑ Renin → ↑ angiotensin II → ↑ aldosterone.

The patient may therefore develop:

Hypertension.

Hypokalaemia.

Metabolic alkalosis.

7. Important Correction – Reninoma Does Not Cause Primary Conn Syndrome

The original note states that a renin-secreting tumour:

“Leads to Conn syndrome.”

This is not strictly correct.

Conn syndrome refers to primary hyperaldosteronism, in which aldosterone is produced autonomously, usually by the adrenal gland, and renin is suppressed.

In a reninoma:

Renin is high → aldosterone becomes high secondarily.

Therefore, the correct term is:

Secondary hyperaldosteronism.

8. Reninoma versus Conn Syndrome

Reninoma:

Renin ↑.

Aldosterone ↑.

Secondary hyperaldosteronism.

Conn syndrome:

Renin ↓.

Aldosterone ↑.

Primary hyperaldosteronism.

This distinction is clinically important.

9. Renal Cell Carcinoma

Renal cell carcinoma (RCC) is the most important primary malignant tumour arising from the renal parenchyma in adults.

It originates from:

Renal tubular epithelial cells.

Several histological subtypes exist.

10. Clear Cell Renal Cell Carcinoma

The most common subtype is:

Clear cell RCC.

It commonly arises from:

Proximal tubular epithelial cells.

Alterations involving the:

VHL tumour-suppressor pathway

are particularly important in clear cell RCC.

11. Von Hippel–Lindau Disease

Inherited von Hippel–Lindau disease markedly increases the risk of:

Clear cell RCC.

Other manifestations can include:

Retinal haemangioblastomas.

CNS haemangioblastomas.

Phaeochromocytomas in some patients.

Pancreatic lesions.

RCC may be bilateral or multifocal in hereditary disease.

12. Risk Factors for Renal Cell Carcinoma

Important established risk factors include:

Cigarette smoking.

Obesity.

Hypertension.

Chronic kidney disease.

Acquired cystic kidney disease, particularly in long-term dialysis.

Certain inherited syndromes, especially VHL disease.

Some occupational and chemical exposures have also been investigated.

13. Smoking

Smoking is an important modifiable risk factor for RCC.

Risk generally increases with greater cumulative exposure.

Smoking cessation reduces long-term risk.

14. Hypertension

Hypertension is independently associated with an increased risk of RCC.

It is important to distinguish this from hypertension occurring as a:

Manifestation of an existing RCC

through mechanisms such as renin secretion.

Thus hypertension may be both a background risk association and, less commonly, part of the tumour’s clinical presentation.

15. Chronic Kidney Disease and Transplantation

Patients with advanced chronic kidney disease, particularly those with:

Long-term dialysis and acquired cystic kidney disease,

have an increased risk of RCC.

Renal transplant recipients also have an increased overall risk of malignancy because of immunosuppression, and native-kidney RCC is an important consideration in this population.

16. Analgesic Exposure

Older teaching often lists:

Analgesic abuse

as a risk factor for renal tract malignancy.

A particularly strong classical association is between analgesic nephropathy, especially historical phenacetin-containing analgesics, and:

Upper urinary tract urothelial carcinoma.

Its relationship with RCC is less central than the major established RCC risks such as smoking, obesity, hypertension, and acquired cystic kidney disease.

17. Solvents and Heavy Metals

Some occupational exposures have been investigated as potential RCC risks.

However, the broad statement:

“Solvents or heavy metals cause RCC”

is too general.

For examination purposes, the most reliable major risk factors to prioritise are:

Smoking + obesity + hypertension + chronic renal disease/acquired cystic disease + hereditary syndromes.

18. Clinical Presentation of RCC

Renal cell carcinoma can remain asymptomatic for a long time.

Many cases are now discovered:

Incidentally on abdominal imaging.

When symptomatic, possible features include:

Haematuria.

Loin or flank pain.

Abdominal or flank mass.

Fever.

Weight loss.

Anaemia or polycythaemia.

Hypertension.

Paraneoplastic syndromes.

19. Classical Triad of RCC

The classical triad is:

Haematuria.

Flank pain.

Palpable abdominal mass.

However, the complete triad is uncommon and usually suggests relatively advanced disease.

Therefore, absence of the triad does not exclude RCC.

20. Haematuria

Haematuria is an important presenting feature.

It may be:

Visible haematuria

or

Microscopic haematuria.

Unexplained visible haematuria requires appropriate investigation for urinary tract malignancy.

21. Loin Pain

RCC may cause:

Persistent flank or loin discomfort.

Pain may result from:

Tumour expansion.

Local invasion.

Bleeding.

Obstruction.

22. Abdominal Mass

A sufficiently large renal tumour may become palpable as an:

Abdominal or flank mass.

This is generally a relatively late finding.

23. Pyrexia of Unknown Origin

RCC is classically associated with:

Unexplained fever.

Historically it is an important malignant cause of:

Pyrexia of unknown origin.

This reflects tumour-associated inflammatory cytokine production.

24. Paraneoplastic Syndromes

RCC is particularly notable for producing:

Paraneoplastic syndromes.

These may occasionally dominate the clinical presentation.

Important examples include:

Polycythaemia.

Hypercalcaemia.

Hypertension.

Fever.

Hepatic dysfunction without liver metastases.

25. Polycythaemia

Some RCCs produce excessive:

Erythropoietin.

This stimulates erythropoiesis and can cause:

Secondary polycythaemia.

Therefore:

RCC → ↑ EPO → ↑ red-cell production → polycythaemia.

However, anaemia is also common in patients with RCC, so polycythaemia is a classic but relatively uncommon manifestation.

26. Hypercalcaemia

RCC can cause:

Hypercalcaemia.

This may occur through tumour-mediated humoral mechanisms or metastatic bone disease.

It is another important paraneoplastic association.

27. Hypertension

RCC may occasionally produce hypertension through increased:

Renin activity.

Other mechanisms, including renal vascular compression, may contribute.

Therefore:

RCC → renin-related mechanisms → hypertension.

28. Stauffer Syndrome

RCC can cause abnormal liver function despite the absence of hepatic metastases.

This is called:

Stauffer syndrome.

It is a paraneoplastic hepatic dysfunction associated classically with RCC.

29. Renal Vein Invasion

RCC has a characteristic tendency to invade veins.

The tumour may extend into the:

Renal vein.

From there, it can extend into the:

Inferior vena cava.

In advanced cases, tumour thrombus may extend superiorly within the IVC.

30. Left-Sided Varicocele

The:

Left testicular vein

drains into the:

Left renal vein.

Therefore, obstruction of the left renal vein by a renal tumour may impair testicular venous drainage.

This can produce a:

Left-sided varicocele.

31. Suspicious Varicocele

A new:

Left-sided varicocele

particularly in an older adult, especially if it does not decompress when supine, should raise concern for obstruction of venous drainage, including a possible renal or retroperitoneal mass.

A new isolated right-sided varicocele may also warrant investigation for retroperitoneal pathology.

32. Metastatic Spread of RCC

RCC can spread:

Directly into surrounding structures.

Through the renal vein and IVC.

Through lymphatics.

Haematogenously.

Common metastatic sites include:

Lungs.

Bones.

Liver.

Brain.

33. Diagnosis of RCC

Renal masses are commonly evaluated using:

Ultrasound.

Contrast-enhanced CT.

MRI in selected circumstances.

CT of the abdomen and pelvis is particularly important for assessing:

Tumour size.

Local invasion.

Renal vein or IVC involvement.

Lymph nodes.

Metastatic disease.

34. Treatment of Localised RCC

Surgery is the major treatment for localised RCC.

Depending on tumour size and location, options include:

Partial nephrectomy

or

Radical nephrectomy.

Nephron-sparing surgery is preferred when oncologically appropriate.

35. Wilms Tumour

Wilms tumour, or:

Nephroblastoma,

is an embryonal malignant renal tumour occurring predominantly in:

Children.

It arises from primitive nephrogenic tissue.

36. Presentation of Wilms Tumour

A typical presentation is:

Painless abdominal mass in a child.

Other possible features include:

Abdominal pain.

Haematuria.

Hypertension.

Fever.

The abdominal mass may be discovered by a parent during bathing or dressing.

37. Wilms Tumour Associations

Wilms tumour has important associations with several congenital syndromes.

These include:

WAGR syndrome.

Denys–Drash syndrome.

Beckwith–Wiedemann syndrome.

38. WAGR Syndrome

WAGR refers to:

W – Wilms tumour.

A – Aniridia.

G – Genitourinary abnormalities.

R – Developmental delay, historically termed intellectual retardation.

This syndrome is associated with abnormalities involving chromosome 11p.

39. Urothelial Tumours

Tumours arising from the lining of the urinary tract are called:

Urothelial carcinomas.

The older term is:

Transitional cell carcinoma.

Modern terminology generally prefers:

Urothelial carcinoma.

40. Sites of Urothelial Carcinoma

Urothelium lines the:

Renal pelvis.

Ureters.

Urinary bladder.

Parts of the urethra.

Therefore, urothelial carcinoma can occur at multiple sites along the urinary tract.

The:

Bladder

is by far the most common site.

41. Presentation of Urothelial Carcinoma

The classic presentation is:

Painless visible haematuria.

This is one of the most important clinical warning signs.

Other possible manifestations include:

Urinary frequency.

Urgency.

Dysuria.

Flank pain or obstruction if the upper tract is involved.

42. Urinary Tract Obstruction

A urothelial tumour can obstruct:

A ureter.

The ureteric orifice.

The bladder outlet in selected cases.

Upper tract obstruction may cause:

Hydronephrosis.

Flank pain.

Renal impairment.

43. Multifocality

Urothelial carcinoma may be:

Multifocal.

This reflects the exposure of a large area of urothelium to carcinogenic influences and the biological tendency of urothelial malignancy to recur at different sites.

Therefore, long-term surveillance is often important.

44. Smoking and Urothelial Carcinoma

The most important risk factor is:

Cigarette smoking.

Tobacco carcinogens are absorbed, metabolised, and eventually excreted in urine, exposing the urothelium.

Smoking is therefore a major risk factor for:

Bladder urothelial carcinoma

and

Upper urinary tract urothelial carcinoma.

45. Occupational Exposure

Certain occupational aromatic amines are associated with urothelial carcinoma.

Historical high-risk industries include:

Dye manufacture.

Rubber industry.

Leather and chemical industries.

The classical association with:

Aniline dye exposure

reflects exposure to carcinogenic aromatic amines.

46. Analgesic Nephropathy

Historical heavy exposure to certain analgesics, particularly:

Phenacetin-containing preparations,

was associated with:

Analgesic nephropathy

and an increased risk of:

Upper urinary tract urothelial carcinoma.

This is an important classical examination association.

47. Renal Calculi and Chronic Irritation

Chronic urinary tract irritation and inflammation can predispose to malignant transformation.

However, renal calculi are particularly associated with chronic irritation and an increased risk of:

Squamous cell carcinoma

rather than being one of the strongest classic risk factors for ordinary urothelial carcinoma.

This distinction is useful.

48. Schistosomiasis

Chronic infection with:

Schistosoma haematobium

is strongly associated with:

Squamous cell carcinoma of the bladder.

Therefore, the original association between schistosomiasis and “transitional cell tumours” needs correction.

The high-yield association is:

Schistosoma haematobium → chronic bladder inflammation → squamous cell carcinoma.

49. Squamous Cell Carcinoma of the Bladder

Squamous cell carcinoma is much less common than urothelial carcinoma in many regions.

It is associated with chronic irritation, particularly:

Schistosomiasis.

Long-standing bladder stones.

Chronic catheterisation or chronic inflammation.

50. Renal Cell Carcinoma – Note Form

Origin:

Renal tubular epithelium.

Clear cell RCC is the most common subtype.

Major risk factors:

Smoking.

Obesity.

Hypertension.

Chronic kidney disease/acquired cystic kidney disease.

Hereditary syndromes such as VHL.

Clinical features:

Haematuria.

Loin or flank pain.

Abdominal mass.

Fever or PUO.

Weight loss.

Venous invasion:

Renal vein → IVC.

May produce a left-sided varicocele through impaired left gonadal venous drainage.

Paraneoplastic features:

Erythropoietin → polycythaemia.

Renin-related mechanisms → hypertension.

Hypercalcaemia.

Stauffer syndrome.

51. Wilms Tumour – Note Form

Alternative name:

Nephroblastoma.

Age:

Predominantly children.

Origin:

Embryonal nephrogenic tissue.

Typical presentation:

Painless abdominal mass.

Associations:

WAGR.

Denys–Drash.

Beckwith–Wiedemann.

52. Urothelial Carcinoma – Note Form

Older name:

Transitional cell carcinoma.

Origin:

Urothelium.

Sites:

Renal pelvis.

Ureter.

Bladder.

Urethra.

Typical presentation:

Painless visible haematuria.

May cause urinary obstruction.

Behaviour:

Can be multifocal and recurrent.

Major risk factors:

Smoking.

Occupational aromatic amine exposure.

Historical phenacetin/analgesic nephropathy.

53. Important Corrections to the Original Notes

Renin-secreting juxtaglomerular tumour does NOT cause Conn syndrome.

It causes:

Secondary hyperaldosteronism with high renin and high aldosterone.

Conn syndrome is:

Primary hyperaldosteronism with low renin.

The most useful established RCC risk factors to prioritise are:

Smoking + obesity + hypertension + chronic renal disease/acquired cystic kidney disease + hereditary syndromes.

The modern term for:

Transitional cell carcinoma

is:

Urothelial carcinoma.

Schistosoma haematobium is classically associated with:

Squamous cell carcinoma of the bladder, not specifically ordinary urothelial carcinoma.

Likewise, chronic bladder stones and long-standing irritation are particularly important risk factors for:

Squamous cell carcinoma.

Key Clinical Pattern

For renal cell carcinoma, remember:

HAEMATURIA + FLANK PAIN + ABDOMINAL MASS

but the complete triad is uncommon.

Also remember:

RCC LOVES VEINS → RENAL VEIN → IVC.

LEFT RENAL VEIN OBSTRUCTION → LEFT VARICOCELE.

RCC → EPO → POLYCYTHAEMIA.

RCC → RENIN → HYPERTENSION.

RCC → HYPERCALCAEMIA.

For Wilms tumour, think:

CHILD + PAINLESS ABDOMINAL MASS.

For urothelial carcinoma, think:

PAINLESS HAEMATURIA + SMOKING + AROMATIC AMINE EXPOSURE + MULTIFOCALITY.

And keep the important distinction:

SCHISTOSOMA HAEMATOBIUM → SQUAMOUS CELL CARCINOMA OF BLADDER.

Medicine – Urinary Tract Infections

A urinary tract infection (UTI) is an infection involving any part of the urinary system, including the urethra, bladder, ureters, or kidneys. Most UTIs are caused by bacteria that ascend from the periurethral region into the urinary tract.

UTIs can be broadly divided into lower UTI, particularly cystitis, and upper UTI, particularly pyelonephritis.

1. Escherichia coli

Escherichia coli (E. coli) is by far the most common cause of community-acquired UTI.

Traditionally, it accounts for approximately:

60–90% of uncomplicated UTIs, depending on the population studied.

E. coli normally colonises the gastrointestinal tract and can spread from the perineal region to the urethra before ascending into the bladder.

2. Why E. coli Commonly Causes UTI

Certain strains of E. coli possess virulence factors that allow them to:

Adhere to urinary epithelium.

Resist being washed away by urine.

Ascend through the urinary tract.

These strains are sometimes referred to as:

Uropathogenic E. coli.

3. Enterococci

Enterococcus species can cause UTIs, particularly in:

Hospitalised patients.

Older adults.

Patients with urinary catheters.

Patients with structural urinary tract abnormalities.

They are especially important in healthcare-associated and complicated UTIs.

4. Proteus Species

Proteus, particularly Proteus mirabilis, is an important urinary pathogen.

It produces the enzyme:

Urease.

Urease breaks down urea and makes the urine more alkaline.

5. Proteus and Renal Stones

Alkaline urine promotes formation of:

Magnesium ammonium phosphate stones.

These are called:

Struvite stones.

Large struvite stones may form:

Staghorn calculi.

Therefore, a useful association is:

Proteus → urease → alkaline urine → struvite stones.

6. Enterobacter Species

Enterobacter species can cause UTIs, particularly in:

Hospitalised patients.

Patients with urinary instrumentation.

Patients receiving antibiotics.

Patients with complicated urinary tract disease.

Antibiotic resistance may complicate treatment.

7. Pseudomonas Species

Pseudomonas aeruginosa is particularly associated with:

Healthcare-associated UTI.

Long-term urinary catheterisation.

Urinary tract instrumentation.

Structural urinary tract abnormalities.

Previous broad-spectrum antibiotic exposure.

It is less typical as a cause of uncomplicated community-acquired cystitis.

8. Klebsiella Species

Klebsiella species, especially Klebsiella pneumoniae, are another important cause of UTI.

They are more commonly encountered in:

Complicated infections.

Hospital-acquired infections.

Patients with diabetes.

Patients with urinary tract abnormalities or catheters.

9. Tuberculosis

Mycobacterium tuberculosis can infect the genitourinary tract.

However, it should not be thought of as a typical cause of an ordinary acute bacterial UTI.

Genitourinary TB classically produces:

Persistent sterile pyuria.

Routine bacterial urine cultures may remain negative because special mycobacterial investigations are required.

10. Other Important Organisms

Other organisms may cause UTIs depending on the clinical setting.

An important example is:

Staphylococcus saprophyticus.

It is a recognised cause of uncomplicated cystitis, particularly in:

Young sexually active women.

11. Predisposing Factors for UTI

Several factors increase the risk of developing a urinary tract infection.

These generally work by:

Facilitating bacterial entry.

Producing urinary stasis.

Preventing complete bladder emptying.

Allowing reflux of infected urine.

or

Reducing host defence mechanisms.

12. Female Sex

UTIs are considerably more common in females.

An important anatomical reason is the:

Shorter female urethra.

The female urethral opening is also relatively close to the:

Perineum and anus.

This makes ascending infection by gastrointestinal organisms such as E. coli easier.

13. Sexual Activity

Sexual intercourse can facilitate movement of bacteria into the urethra and bladder.

Therefore:

Sexual activity

is an important risk factor for cystitis, particularly in younger women.

14. Urinary Catheterisation

A urinary catheter is an important risk factor for UTI.

Catheters can:

Introduce organisms into the urinary tract.

Provide a surface for bacterial biofilm formation.

Bypass normal mechanical defences.

The risk increases with increasing duration of catheterisation.

15. Catheter-Associated UTI

Catheter-associated urinary tract infection is an important healthcare-associated infection.

The most effective preventive principle is:

Avoid unnecessary catheterisation and remove the catheter as soon as it is no longer required.

Long-term catheterisation is often associated with colonisation, so bacteriuria alone does not necessarily mean symptomatic infection.

16. Bladder Outflow Obstruction

Anything that prevents complete bladder emptying increases the risk of infection.

Urinary stasis allows bacteria to remain within the bladder and multiply.

Important causes include:

Benign prostatic enlargement.

Prostate cancer.

Urethral stricture.

Bladder neck obstruction.

17. Residual Urine

Normally, regular bladder emptying helps clear bacteria.

When significant residual urine remains:

Urinary stasis → bacterial multiplication → increased UTI risk.

This explains why obstruction and impaired bladder emptying are major predisposing factors.

18. Anatomical Abnormalities of the Bladder

Structural abnormalities can interfere with normal urinary drainage.

Examples include:

Bladder diverticula.

Bladder tumours.

A diverticulum can retain residual urine and provide a site for recurrent infection.

19. Vesicoureteric Reflux

Vesicoureteric reflux (VUR) is abnormal backward movement of urine from the bladder into the ureters and potentially toward the kidneys.

It is particularly important in children.

VUR can predispose to:

Recurrent UTI.

Pyelonephritis.

Renal scarring.

20. Reflux Nephropathy

Repeated infection in the presence of significant vesicoureteric reflux can contribute to renal scarring.

This may lead to:

Reflux nephropathy.

Long-term complications can include:

Hypertension.

Chronic kidney disease.

21. Renal Stones

Urinary calculi predispose to infection by causing:

Urinary obstruction.

Urinary stasis.

Mucosal irritation.

Stones may also provide a surface on which bacteria persist.

22. Infection and Stones Can Reinforce Each Other

The relationship can operate in both directions:

Stone → obstruction/stasis → infection.

and

Urease-producing infection → alkaline urine → struvite stone.

Proteus is the classic organism associated with the second pathway.

23. Pregnancy

Pregnancy increases the risk of UTI because hormonal and mechanical changes produce:

Ureteric dilatation.

Reduced ureteric peristalsis.

Urinary stasis.

The enlarging uterus can further alter urinary drainage.

24. UTI During Pregnancy

UTI is particularly important during pregnancy because bacteriuria can progress to:

Pyelonephritis.

For this reason, asymptomatic bacteriuria in pregnancy is clinically important and is generally screened for and treated according to local obstetric guidance.

25. Diabetes Mellitus

Diabetes increases susceptibility to UTI.

Contributing mechanisms include:

Impaired immune defence.

Glycosuria in some patients.

Autonomic neuropathy causing incomplete bladder emptying.

Higher prevalence of complicated infection.

26. Neurogenic Bladder

Neurological disorders can interfere with normal bladder emptying.

This can produce:

Residual urine.

Urinary retention.

Recurrent infection.

Examples include spinal cord disease and diabetic autonomic neuropathy.

27. Urinary Instrumentation

Procedures involving the urinary tract can introduce bacteria.

Examples include:

Cystoscopy.

Urinary catheter insertion.

Ureteric stenting.

Other urological procedures.

These are particularly relevant to complicated and healthcare-associated UTIs.

28. Lower Urinary Tract Infection

Infection confined mainly to the bladder is called:

Cystitis.

Typical symptoms include:

Dysuria.

Urinary frequency.

Urgency.

Suprapubic discomfort.

Haematuria may occur.

Systemic illness is usually absent or mild.

29. Upper Urinary Tract Infection

Infection involving the kidney is called:

Acute pyelonephritis.

Typical features include:

Fever.

Flank or loin pain.

Costovertebral angle tenderness.

Nausea or vomiting.

Systemic illness.

Lower urinary symptoms may also be present.

30. Complicated UTI

A UTI is considered complicated when factors increase the likelihood of treatment failure or serious infection.

Examples include:

Urinary obstruction.

Stones.

Catheters.

Structural urinary abnormalities.

Renal impairment.

Certain immunocompromised states.

The exact clinical definition varies somewhat between guidelines.

31. Urinalysis

Urine dipstick testing may demonstrate:

Leukocyte esterase, suggesting white blood cells.

Nitrites, suggesting nitrate-reducing bacteria.

Blood, which may occur with infection.

However, dipstick results must be interpreted together with symptoms and the clinical setting.

32. Nitrites

Many Gram-negative urinary pathogens, including E. coli, can convert urinary nitrate to:

Nitrite.

Therefore:

Positive nitrites support bacterial UTI.

However:

Negative nitrites do not exclude UTI.

Some organisms, including enterococci, do not reliably produce nitrites.

33. Urine Culture

Urine culture can:

Identify the causative organism.

and

Determine antimicrobial susceptibility.

Culture is particularly important in:

Pyelonephritis.

Recurrent UTI.

Complicated UTI.

Pregnancy.

Men with suspected UTI.

Treatment failure.

34. Causes of UTI – Note Form

Escherichia coli:

Most common cause of uncomplicated UTI.

Approximately 60–90% in traditional teaching, depending on population.

Enterococci:

Important in complicated, catheter-associated and healthcare-associated infections.

Proteus:

Urease-producing organism.

Causes alkaline urine.

Associated with struvite and staghorn stones.

Enterobacter:

More important in complicated and healthcare-associated infections.

Pseudomonas:

Associated with catheters, instrumentation, structural abnormalities and healthcare exposure.

Klebsiella:

Important Gram-negative urinary pathogen, particularly in complicated and healthcare-associated infections.

Tuberculosis:

Atypical genitourinary infection.

Think of persistent sterile pyuria.

Staphylococcus saprophyticus:

Important additional cause, particularly in young sexually active women.

35. Predisposing Factors – Note Form

Female sex:

Short urethra facilitates ascending infection.

Urinary catheter:

Introduces organisms and allows biofilm formation.

Bladder outflow obstruction:

Causes urinary stasis and residual urine.

Bladder abnormalities:

Diverticula and tumours can impair normal emptying.

Vesicoureteric reflux:

Allows infected urine to reflux toward the kidneys.

Renal stones:

Cause obstruction and provide a focus for persistent infection.

Pregnancy:

Ureteric dilatation and reduced urinary drainage increase risk.

Diabetes:

Impaired host defence and bladder dysfunction increase susceptibility.

Sexual activity:

Important additional risk factor, especially in younger women.

Neurogenic bladder:

Incomplete emptying and residual urine predispose to infection.

Urinary instrumentation:

Can introduce organisms directly into the urinary tract.

36. Important Corrections to the Original Notes

E. coli remains the most important organism, but the exact percentage varies considerably between populations and between uncomplicated and complicated infections.

TB is not a typical cause of ordinary acute cystitis. It is better considered separately as:

Genitourinary tuberculosis, particularly when there is persistent sterile pyuria.

An important organism missing from the original list is:

Staphylococcus saprophyticus, particularly in young sexually active women.

Pseudomonas, Enterobacter and Enterococcus are especially important when there are:

Catheters, hospital exposure, structural abnormalities, or complicated urinary disease.

Key Clinical Pattern

The most important organism is:

E. COLI = MOST COMMON UTI.

Remember the classic association:

PROTEUS → UREASE → ALKALINE URINE → STRUVITE / STAGHORN STONES.

For persistent culture-negative pyuria:

THINK GENITOURINARY TB.

Major predisposing factors can be remembered as anything producing:

BACTERIAL ENTRY + URINARY STASIS + OBSTRUCTION + REFLUX + IMPAIRED HOST DEFENCE.

High-yield examples are:

FEMALE SEX + CATHETER + OBSTRUCTION + VUR + STONES + PREGNANCY + DIABETES.

Medicine – Causes of Sterile Pyuria

Sterile pyuria means the presence of white blood cells in the urine despite a negative routine bacterial urine culture. It is not a diagnosis by itself, but a laboratory finding that should prompt consideration of recent antibiotic treatment, atypical infections, renal inflammation, stones, malignancy, and other urinary tract disorders.

1. Recently Treated Urinary Tract Infection

A very common cause of sterile pyuria is a:

Recently treated UTI.

Antibiotics may suppress or eliminate bacterial growth before the urine sample is collected, while inflammatory white blood cells remain in the urine.

Therefore:

Recent UTI + antibiotics → pyuria may persist even though culture becomes negative.

2. Genitourinary Tuberculosis

Tuberculosis of the urinary tract is an important classical cause of persistent sterile pyuria.

It should be considered particularly when there is:

Persistent pyuria with repeated negative routine cultures.

Haematuria.

Flank pain.

Constitutional symptoms.

Past TB exposure or residence in a high-prevalence area.

3. Why TB Causes Sterile Pyuria

Routine urine culture does not detect:

Mycobacterium tuberculosis

using standard bacterial culture methods.

Therefore, the urine may show:

White blood cells

while routine culture remains:

Negative.

Specific testing may include:

Mycobacterial urine culture.

Nucleic acid amplification tests where appropriate.

Classically, multiple early-morning urine samples are collected when genitourinary TB is suspected.

4. Acute Interstitial Nephritis

Acute interstitial nephritis, or AIN, is inflammation of the renal interstitium and tubules.

It is commonly caused by:

Drugs.

Important examples include:

Antibiotics.

NSAIDs.

Proton-pump inhibitors.

It may also occur with infections or systemic inflammatory disease.

5. Urinary Findings in Acute Interstitial Nephritis

AIN may produce:

Sterile pyuria.

Mild proteinuria.

Microscopic haematuria.

Sometimes:

White-cell casts.

The older association with urine eosinophils is not reliable enough to confirm or exclude the diagnosis.

6. Clinical Features of Acute Interstitial Nephritis

Patients may develop:

Acute kidney injury.

Fever.

Rash.

Arthralgia.

However, the classic triad of:

Fever + rash + eosinophilia

is present in only a minority of cases.

A careful medication history is therefore particularly important.

7. Chronic Interstitial Nephritis

Chronic interstitial nephritis can also cause sterile pyuria.

This condition involves long-standing inflammation and fibrosis of the renal interstitium.

Possible causes include:

Long-term drug or toxin exposure.

Reflux nephropathy.

Obstructive urinary disease.

Metabolic disorders.

8. Chronic Pyelonephritis

Chronic pyelonephritis refers to chronic renal scarring associated particularly with:

Recurrent infection.

Vesicoureteric reflux.

Urinary obstruction.

Patients may have pyuria even when routine cultures are negative, especially if infection is intermittent or antibiotics have already been given.

9. Important Additional Cause – Sexually Transmitted Infection

An important modern addition is:

Urethritis due to sexually transmitted infection.

In sexually active patients, particularly younger adults, sterile pyuria may occur with:

Chlamydia trachomatis.

Neisseria gonorrhoeae.

Other causes of urethritis may also contribute.

Routine midstream urine culture may be negative because these organisms require different diagnostic tests.

10. Chlamydia

Chlamydia trachomatis is a particularly important cause of sterile pyuria in younger sexually active patients.

Possible symptoms include:

Dysuria.

Urethral discharge.

Pelvic symptoms.

However, infection may also be asymptomatic.

Diagnosis is usually made with:

Nucleic acid amplification testing.

11. Renal Stones

Renal or ureteric calculi can cause urinary tract inflammation and therefore:

Pyuria without bacterial infection.

Patients may also have:

Haematuria.

Renal colic.

Flank pain.

12. Urinary Tract Malignancy

Tumours involving the urinary tract may occasionally produce sterile pyuria.

Examples include:

Bladder cancer.

Renal malignancy.

Clinical clues may include:

Haematuria.

Weight loss.

Persistent urinary symptoms.

13. Prostatitis

In men, inflammation or infection involving the prostate may occasionally be associated with:

Pyuria with negative routine midstream culture.

This may occur particularly after partial treatment or with organisms not detected on standard culture.

14. Contamination

Not all apparent sterile pyuria represents urinary tract disease.

A urine sample can be contaminated by leukocytes from the:

Vagina.

Vulva.

Urethral opening.

For this reason, a properly collected:

Clean-catch midstream urine

is important before extensive investigation.

15. Sterile Pyuria – Note Form

Recently treated UTI:

Antibiotics suppress bacterial growth while white cells persist.

Genitourinary TB:

Classical cause of persistent sterile pyuria.

Routine bacterial cultures are negative.

Acute interstitial nephritis:

Often drug-induced.

May cause AKI, sterile pyuria, haematuria, and white-cell casts.

Chronic interstitial nephritis:

Chronic tubulointerstitial inflammation and fibrosis may produce persistent pyuria.

Chronic pyelonephritis:

Associated with renal scarring, reflux, obstruction, and recurrent infection.

Sexually transmitted infection:

Especially chlamydial urethritis.

Renal calculi:

Inflammation from stones may cause pyuria without infection.

Urinary tract malignancy:

Consider particularly with persistent haematuria or other concerning features.

16. Practical Approach

When sterile pyuria is found, first consider:

Was the patient recently given antibiotics?

Then ask:

Could this be an STI?

Could this be TB?

Could there be interstitial nephritis?

Could stones, obstruction, or malignancy be present?

Repeating a properly collected urine sample is often useful because contamination or partially treated infection is common.

17. Important Corrections to the Original Notes

Your original list contains important causes, but it is incomplete.

A particularly important addition is:

Sexually transmitted urethritis, especially Chlamydia trachomatis.

Chronic pyelonephritis may cause pyuria, but if recurrent bacterial infection is active, the culture may be positive. A negative culture is more likely after antibiotics, intermittent infection, or when another inflammatory process is present.

Sterile pyuria does not literally mean that the urinary tract contains no microorganisms.

It means:

Pyuria + negative routine bacterial culture.

Atypical organisms such as TB or chlamydia may still be present.

Key Clinical Pattern

Think:

STERILE PYURIA = WBCs IN URINE + ROUTINE CULTURE NEGATIVE.

High-yield causes include:

RECENTLY TREATED UTI.

TB.

ACUTE INTERSTITIAL NEPHRITIS.

CHRONIC INTERSTITIAL NEPHRITIS.

CHRONIC PYELONEPHRITIS.

And important additions:

CHLAMYDIA / URETHRITIS.

RENAL STONES.

URINARY TRACT MALIGNANCY.

A useful exam pattern is:

YOUNG + DYSURIA + STERILE PYURIA → THINK CHLAMYDIA.

PERSISTENT STERILE PYURIA + TB RISK → THINK GENITOURINARY TB.

AKI + NEW DRUG + STERILE PYURIA → THINK ACUTE INTERSTITIAL NEPHRITIS.

Medicine – The Cerebral Cortex

The cerebral cortex is the outer layer of the cerebral hemispheres and is responsible for many higher neurological functions, including voluntary movement, sensation, vision, hearing, language, memory, cognition, and behaviour.

Different cortical regions have specialised functions, so focal lesions can often be localised from the pattern of neurological deficits.

1. Primary Motor Cortex

The primary motor cortex is located in the:

Precentral gyrus of the frontal lobe.

It is responsible for initiating voluntary movements of the opposite side of the body.

2. Motor Homunculus

The body is represented somatotopically within the motor cortex.

Approximately:

Leg → medial surface.

Arm → superior-lateral region.

Face → lateral/inferior region.

Therefore, a focal cortical lesion can produce weakness affecting a specific body region.

3. Effect of a Motor Cortex Lesion

A lesion of the primary motor cortex produces:

Contralateral upper motor neuron weakness.

Possible signs include:

Weakness.

Increased tone.

Brisk reflexes.

Extensor plantar response.

The exact distribution depends on the affected cortical area.

4. Primary Somatosensory Cortex

The primary somatosensory cortex is located in the:

Postcentral gyrus of the parietal lobe.

It receives sensory information from the opposite side of the body.

5. Sensory Functions

The somatosensory cortex processes information including:

Touch.

Pressure.

Pain-related cortical perception.

Temperature-related cortical perception.

Vibration.

Proprioception.

It also contributes to higher-order cortical sensory interpretation.

6. Sensory Homunculus

Like the motor cortex, the somatosensory cortex is organised somatotopically.

Approximately:

Leg → medial.

Arm → superior-lateral.

Face → lateral/inferior.

A focal lesion may therefore cause contralateral sensory impairment in a particular body region.

7. Higher Cortical Sensory Functions

The parietal association cortex is involved in interpreting sensory information.

Lesions may cause:

Astereognosis.

Agraphesthesia.

Impaired two-point discrimination.

These findings require relatively preserved primary sensation.

8. Primary Auditory Cortex

The primary auditory cortex lies in the superior temporal region, particularly the:

Transverse temporal gyri of Heschl.

This is more precise than simply saying “superotemporal lobe.”

9. Auditory Function

The auditory cortex receives and processes information relating to:

Sound frequency.

Intensity.

Timing.

Speech-related auditory input.

Because central auditory pathways project bilaterally, a unilateral lesion rarely causes complete deafness.

10. Cortical Deafness

True:

Cortical deafness

usually requires:

Bilateral auditory cortical lesions.

The peripheral hearing apparatus may remain intact.

11. Primary Visual Cortex

The primary visual cortex is located in the:

Occipital lobe.

It lies mainly along the:

Calcarine sulcus.

This region receives visual information from the opposite visual field.

12. Visual Field Representation

The left occipital cortex processes the:

Right visual field.

The right occipital cortex processes the:

Left visual field.

Therefore:

Unilateral occipital lesion → contralateral homonymous visual field defect.

13. Effect of Bilateral Occipital Damage

Severe bilateral occipital cortex damage can cause:

Cortical blindness.

Pupillary responses may remain normal because the pupillary light reflex pathway does not require the visual cortex.

14. Olfactory Cortex

The original note states:

Olfactory cortex → frontal lobe.

This is incomplete.

The primary olfactory cortex is mainly located in the:

Medial temporal region

and nearby basal forebrain structures.

Important areas include the:

Piriform cortex.

Uncus.

Amygdala-related regions.

15. Orbitofrontal Olfactory Processing

The frontal lobe is still important in smell, especially the:

Orbitofrontal cortex.

This region contributes to:

Conscious identification of odours.

Discrimination of smells.

Integration of smell with taste and reward.

So it is better to distinguish:

Primary olfactory cortex → mainly medial temporal/basal regions.

Higher olfactory processing → orbitofrontal cortex.

16. Broca Area

Broca area is located in the:

Dominant inferior frontal gyrus.

In most people, the dominant hemisphere is:

Left.

Broca area is involved in:

Speech production.

Language output.

Motor organisation of speech.

17. Broca Aphasia

Damage to Broca area produces:

Non-fluent aphasia.

Speech becomes:

Slow.

Effortful.

Agrammatic.

Reduced in output.

Comprehension is relatively preserved, especially for simple language.

18. Wernicke Area

Wernicke area is classically located in the:

Dominant posterior superior temporal region.

It is strongly involved in:

Language comprehension.

Understanding spoken words.

Semantic processing.

19. Wernicke Aphasia

Damage to this region produces:

Fluent aphasia.

Speech may remain fluent but become:

Meaningless.

Paraphasic.

Filled with incorrect words.

Comprehension is impaired.

20. Broca versus Wernicke

Broca area:

Dominant frontal lobe.

Speech output.

Non-fluent aphasia if damaged.

Comprehension relatively preserved.

Wernicke area:

Dominant posterior temporal region.

Language comprehension.

Fluent but poorly comprehended and poorly meaningful speech if damaged.

21. Language Network

Modern understanding recognises that language is not confined to only Broca and Wernicke areas.

Language depends on a distributed network involving:

Frontal cortex.

Temporal cortex.

Parietal cortex.

White-matter connections between them.

The classic Broca-Wernicke model remains useful clinically but is simplified.

22. Arcuate Fasciculus

One important connection between posterior and anterior language regions is the:

Arcuate fasciculus.

Damage can produce:

Conduction aphasia.

Typical features include:

Fluent speech.

Relatively good comprehension.

Markedly impaired repetition.

23. Frontal Association Cortex

The frontal association cortex contributes to:

Planning.

Judgment.

Executive function.

Motivation.

Personality.

Behavioural inhibition.

Lesions may cause apathy, disinhibition, poor planning, and perseveration.

24. Parietal Association Cortex

The parietal association cortex contributes to:

Spatial awareness.

Praxis.

Calculation.

Reading and writing networks.

Body awareness.

Lesions can produce neglect, apraxia, astereognosis, and Gerstmann-type features depending on the hemisphere.

25. Temporal Association Cortex

The temporal association cortex contributes to:

Memory.

Language comprehension.

Auditory recognition.

Emotional processing.

Object and face recognition networks.

Lesions may therefore cause memory disturbance, aphasia, auditory agnosia, or behavioural changes.

26. Occipital Association Cortex

The visual association cortex surrounds the primary visual cortex.

It helps interpret:

Objects.

Faces.

Colour.

Movement.

Damage may cause:

Visual agnosia.

Prosopagnosia.

Colour-processing abnormalities.

27. Cerebral Cortex – Note Form

Primary motor cortex:

Precentral gyrus.

Frontal lobe.

Controls voluntary movement of the contralateral body.

Primary somatosensory cortex:

Postcentral gyrus.

Parietal lobe.

Receives contralateral body sensation.

Primary auditory cortex:

Superior temporal lobe.

Heschl gyri.

Processes sound.

Primary visual cortex:

Occipital lobe.

Around calcarine sulcus.

Processes contralateral visual field.

Primary olfactory cortex:

Mainly medial temporal/basal forebrain regions.

Piriform cortex and uncus important.

Higher olfactory interpretation:

Orbitofrontal cortex.

Broca area:

Dominant inferior frontal gyrus.

Speech production.

Wernicke area:

Dominant posterior superior temporal region.

Language comprehension.

28. Important Corrections to the Original Notes

The auditory cortex is more precisely located in the:

Heschl transverse temporal gyri of the superior temporal lobe.

The primary visual cortex is specifically located around the:

Calcarine sulcus of the occipital lobe.

The statement:

“Olfactory cortex = frontal lobe”

is too simple.

A better description is:

Primary olfactory cortex → mainly medial temporal and basal regions.

Orbitofrontal cortex → higher conscious olfactory interpretation.

Broca area is better described as responsible for:

Speech production and language output

rather than speech alone.

Wernicke area is involved in:

Language comprehension

rather than merely “word comprehension.”

Key Clinical Pattern

Remember:

PREcentral = MOTOR.

POSTcentral = SENSORY.

TEMPORAL = HEARING.

OCCIPITAL = VISION.

BROCA = SPEECH OUTPUT.

WERNICKE = LANGUAGE COMPREHENSION.

And one useful correction:

PRIMARY SMELL = MEDIAL TEMPORAL/BASAL REGION, while ORBITOFRONTAL CORTEX helps identify and interpret odours.

Medicine – Features of Frontal Lobe Lesions

The frontal lobes are responsible for many higher functions, including personality, behaviour, motivation, planning, judgment, executive function, voluntary movement, speech production, and emotional control.

Frontal lobe lesions can therefore produce a broad range of abnormalities involving personality, language, behaviour, motor function, primitive reflexes, and executive ability.

1. Personality Change

One of the most characteristic features of frontal lobe disease is:

Personality change.

The patient may become:

Apathetic and withdrawn

or

Disinhibited and socially inappropriate.

The exact pattern depends partly on which frontal region is affected.

2. Apathy

Damage to medial frontal circuits can produce:

Apathy.

The patient may show:

Reduced initiative.

Loss of interest.

Reduced spontaneous speech.

Reduced emotional responsiveness.

Lack of motivation.

This may be mistaken for depression, although the underlying problem is impaired initiation and drive.

3. Abulia

A more marked reduction in motivation is called:

Abulia.

The patient remains awake and capable of movement but shows very little:

Spontaneous activity.

Speech.

Decision-making.

Initiative.

Severe bilateral medial frontal damage can progress toward:

Akinetic mutism.

4. Disinhibition

Orbitofrontal damage may cause:

Disinhibition.

The patient may become:

Impulsive.

Tactless.

Socially inappropriate.

Overfamiliar.

Irritable.

Sexually disinhibited.

They may understand social rules but fail to regulate behaviour appropriately.

5. Orbitofrontal Syndrome

An orbitofrontal lesion classically causes:

Disinhibition.

Poor judgment.

Impulsivity.

Emotional lability.

Socially inappropriate behaviour.

This reflects loss of normal inhibitory control over behaviour.

6. Broca Aphasia

A lesion involving the dominant inferior frontal gyrus, usually the left hemisphere, may cause:

Broca aphasia.

This is traditionally called:

Expressive aphasia.

7. Features of Broca Aphasia

Speech becomes:

Non-fluent.

Slow.

Effortful.

Agrammatic.

The patient may produce short phrases with omission of small connecting words.

For example, instead of saying:

“I went to the shop to buy food,”

they may say:

“Went shop… buy food.”

8. Comprehension in Broca Aphasia

Language comprehension is:

Relatively preserved, especially for simple sentences.

However, comprehension of complex grammatical structures may still be impaired.

This is why it is more accurate to describe Broca aphasia as:

Non-fluent aphasia

rather than simply “expressive aphasia.”

9. Repetition and Naming

In Broca aphasia:

Repetition is impaired.

Naming may be impaired.

The patient is often aware of the speech difficulty and may become frustrated.

10. Dominant Frontal Lobe

The dominant frontal lobe contributes to:

Speech production.

Verbal fluency.

Motor planning for speech.

A dominant frontal lesion may therefore cause:

Broca aphasia.

Reduced verbal output.

Apraxia of speech in some cases.

11. Abnormal Affective Reactions

Frontal lesions may alter emotional expression and regulation.

Patients may show:

Emotional lability.

Inappropriate laughter or crying.

Reduced emotional response.

Irritability.

Euphoria.

Indifference.

These abnormalities reflect disruption of frontal-limbic connections.

12. Emotional Lability

Emotional lability means rapid and poorly controlled changes in emotional expression.

The patient may:

Laugh inappropriately.

Cry easily.

Switch quickly between emotional states.

This can occur with frontal and other bilateral corticobulbar network lesions.

13. Difficulty Planning

The frontal lobes, especially the prefrontal cortex, are essential for:

Planning.

Organising.

Problem solving.

Decision-making.

Sequencing tasks.

Damage produces:

Executive dysfunction.

14. Executive Dysfunction

Executive dysfunction may cause difficulty with:

Planning a journey.

Managing finances.

Organising daily activities.

Solving unfamiliar problems.

Switching between tasks.

Following multistep instructions.

The patient may appear physically capable but function poorly in complex daily activities.

15. Reduced Motivation

Frontal lobe lesions can impair:

Initiation of behaviour.

The patient may need repeated prompting to:

Start a task.

Continue a task.

Speak.

Eat.

Dress.

This is particularly associated with medial frontal dysfunction.

16. Perseveration

Perseveration means inappropriate repetition of a previous:

Word.

Thought.

Action.

Response.

even when the task has changed.

17. Example of Perseveration

If a patient is asked to:

“Draw a circle,”

then later asked to:

“Draw a square,”

they may continue drawing circles.

This reflects impaired cognitive flexibility.

18. Why Perseveration Occurs

The frontal lobes allow a person to:

Stop an old response

and

Switch to a new strategy.

When frontal control is impaired:

The previous response continues despite changing circumstances.

19. Primitive Reflexes

Frontal lesions may cause the reappearance of:

Primitive reflexes.

These reflexes are present during infancy but are normally suppressed as the frontal lobes mature.

Damage can release them again.

20. Grasp Reflex

The grasp reflex is elicited by stroking or placing an object in the palm.

The patient automatically:

Grasps the object.

They may have difficulty releasing it voluntarily.

This suggests frontal lobe dysfunction, especially medial frontal involvement.

21. Rooting Reflex

The rooting reflex is triggered by touching the cheek or corner of the mouth.

The patient turns the mouth or head toward the stimulus.

This is normal in infants but abnormal in adults.

22. Pout Reflex

The pout reflex is produced by tapping around the lips.

The lips protrude or purse.

A marked response may occur in:

Frontal lobe disease.

However, isolated primitive reflexes are not highly specific and are more useful when combined with other frontal signs.

23. Palmomental Reflex

Another frontal release sign is the:

Palmomental reflex.

Scratching the thenar eminence causes contraction of the:

Ipsilateral mentalis muscle.

Like other primitive reflexes, it can be seen in frontal dysfunction but may also occur in older healthy adults.

24. Utilisation Behaviour

Some frontal lesions cause:

Utilisation behaviour.

The patient automatically uses objects placed in front of them even when not instructed to do so.

For example, they may:

Put on glasses placed on the table.

Pick up and use a comb automatically.

This reflects impaired suppression of stimulus-driven behaviour.

25. Imitation Behaviour

Patients with frontal dysfunction may automatically imitate:

Gestures.

Movements.

Actions

performed by the examiner.

This is called:

Imitation behaviour.

26. Motor Weakness

The frontal lobe contains the:

Primary motor cortex.

Therefore, a lesion involving the precentral gyrus can cause:

Contralateral upper motor neuron weakness.

The distribution depends on which part of the motor homunculus is affected.

27. Frontal Motor Cortex

The motor homunculus is arranged approximately as:

Leg medially.

Arm more superior-lateral.

Face most lateral.

Therefore, focal frontal lesions can produce selective weakness depending on location.

28. Anterior Cerebral Artery Lesions

The anterior cerebral artery supplies the medial frontal lobe.

An ACA stroke may therefore cause:

Contralateral leg-predominant weakness.

Abulia.

Reduced motivation.

Behavioural change.

Urinary incontinence in some cases.

29. Frontal Eye Fields

The frontal eye fields help control voluntary horizontal eye movements.

An acute destructive frontal eye field lesion may cause the eyes to deviate:

Toward the side of the lesion.

For example:

Left frontal lesion → eyes may deviate left.

This can be seen in large frontal strokes.

30. Urinary Incontinence

Medial frontal lesions can impair voluntary bladder control.

This may produce:

Urinary urgency

or

Incontinence.

It is particularly seen with bilateral or medial frontal dysfunction.

31. Frontal Gait Disorder

Medial frontal lesions may produce difficulty initiating walking.

The patient may have:

Short steps.

Gait freezing.

Magnetic gait-like features.

This can resemble the gait seen in:

Normal pressure hydrocephalus.

32. Dorsolateral Prefrontal Syndrome

Damage to the dorsolateral prefrontal cortex typically causes:

Executive dysfunction.

Features include:

Poor planning.

Reduced mental flexibility.

Difficulty problem-solving.

Impaired working memory.

Perseveration.

33. Medial Frontal Syndrome

Medial frontal damage tends to cause:

Apathy.

Abulia.

Reduced spontaneous activity.

Reduced speech.

Gait initiation problems.

Severe bilateral lesions may cause:

Akinetic mutism.

34. Orbitofrontal Syndrome

Orbitofrontal damage tends to cause:

Disinhibition.

Impulsivity.

Poor social judgment.

Emotional instability.

Inappropriate behaviour.

35. Frontal Lobe Seizures

Frontal lobe lesions may also produce:

Focal seizures.

These may be:

Brief.

Frequent.

Motor-predominant.

Sometimes bizarre in appearance.

Some occur mainly during sleep.

36. Causes of Frontal Lobe Lesions

Important causes include:

Stroke.

Brain tumour.

Traumatic brain injury.

Frontotemporal dementia.

Multiple sclerosis or other demyelinating disease.

Infection or inflammatory disease.

Hydrocephalus affecting frontal-subcortical pathways.

37. Frontotemporal Dementia

Frontotemporal dementia often affects frontal and anterior temporal networks.

Early features may include:

Personality change.

Disinhibition.

Apathy.

Loss of empathy.

Compulsive behaviour.

Dietary change.

Executive dysfunction.

Memory may be relatively less affected early than in Alzheimer disease.

38. Frontal Lobe Lesion – Note Form

Personality:

Apathy or disinhibition.

Language:

Broca aphasia with dominant inferior frontal lesion.

Affect:

Emotional lability or abnormal emotional responses.

Executive function:

Poor planning.

Poor judgment.

Reduced mental flexibility.

Difficulty solving problems.

Motivation:

Reduced initiative.

Apathy.

Abulia.

Primitive reflexes:

Grasp.

Rooting.

Pout.

Palmomental.

Perseveration:

Inappropriate repetition of the same response or action.

39. Frontal Regions – Note Form

Dorsolateral prefrontal cortex:

Executive dysfunction.

Poor planning.

Perseveration.

Impaired working memory.

Orbitofrontal cortex:

Disinhibition.

Impulsivity.

Poor social judgment.

Emotional lability.

Medial frontal cortex:

Apathy.

Abulia.

Reduced initiation.

Gait problems.

Urinary incontinence.

Dominant inferior frontal gyrus:

Broca aphasia.

40. Important Corrections to the Original Notes

Broca aphasia is better described as a non-fluent aphasia rather than simply “expressive aphasia.” Speech is effortful and agrammatic, while comprehension is relatively preserved.

Primitive reflexes such as grasp, rooting, and pout are called:

Frontal release signs.

They suggest loss of frontal inhibitory control but are not completely specific.

Difficulty planning or maintaining motivation represents two related but distinct frontal problems:

Executive dysfunction particularly with dorsolateral lesions.

and

Apathy/abulia particularly with medial frontal lesions.

Personality change can vary depending on lesion location:

Orbitofrontal → disinhibited.

Medial frontal → apathetic/abulic.

Dorsolateral → executive dysfunction.

Key Clinical Pattern

Think of the frontal lobe as:

PERSONALITY + PLANNING + SPEECH + MOTOR CONTROL + INHIBITION.

The classic patterns are:

ORBITOFRONTAL → DISINHIBITED.

MEDIAL FRONTAL → APATHETIC / ABULIC.

DORSOLATERAL → POOR PLANNING + PERSEVERATION.

DOMINANT INFERIOR FRONTAL → BROCA APHASIA.

And remember the classic frontal release signs:

GRASP + ROOTING + POUT.